{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 599, "items": [{"indexed": {"date-parts": [[2019, 12, 17]], "date-time": "2019-12-17T04:10:03Z", "timestamp": 1576555803794}, "reference-count": 22, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 6, 1]], "date-time": "2001-06-01T00:00:00Z", "timestamp": 991353600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochemical and Biophysical Research Communications"], "published-print": {"date-parts": [[2001, 6]]}, "DOI": "10.1006/bbrc.2001.5098", "type": "journal-article", "created": {"date-parts": [[2002, 9, 16]], "date-time": "2002-09-16T13:50:03Z", "timestamp": 1032184203000}, "page": "1189-1193", "source": "Crossref", "is-referenced-by-count": 62, "title": ["FMRFamide-Related Neuropeptides Are Agonists of the Orphan G-Protein-Coupled Receptor GPR54"], "prefix": "10.1006", "volume": "284", "author": [{"given": "Michelle K.", "family": "Clements", "sequence": "first", "affiliation": []}, {"given": "Terrence P.", "family": "McDonald", "sequence": "additional", "affiliation": []}, {"given": "Ruiping", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Guochun", "family": "Xie", "sequence": "additional", "affiliation": []}, {"given": "Brian F.", "family": "O'Dowd", "sequence": "additional", "affiliation": []}, {"given": "Susan R.", "family": "George", "sequence": "additional", "affiliation": []}, {"given": "Christopher P.", "family": "Austin", "sequence": "additional", "affiliation": []}, {"given": "Qingyun", "family": "Liu", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biochemical and Biophysical Research Communications"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0006291X01950983?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0006291X01950983?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 12, 17]], "date-time": "2019-12-17T03:49:21Z", "timestamp": 1576554561000}, "score": 56.94529, "issued": {"date-parts": [[2001, 6]]}, "references-count": 22, "journal-issue": {"published-print": {"date-parts": [[2001, 6]]}, "issue": "5"}, "alternative-id": ["S0006291X01950983"], "URL": "http://dx.doi.org/10.1006/bbrc.2001.5098", "ISSN": ["0006-291X"], "issn-type": [{"value": "0006-291X", "type": "print"}], "subject": ["Biophysics", "Cell Biology", "Biochemistry", "Molecular Biology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T21:48:21Z", "timestamp": 1574804901495}, "reference-count": 102, "publisher": "Walter de Gruyter GmbH", "issue": "2", "license": [{"URL": "http://creativecommons.org/licenses/by-nc-nd/3.0", "start": {"date-parts": [[2017, 6, 30]], "date-time": "2017-06-30T00:00:00Z", "timestamp": 1498780800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2017, 6, 30]]}, "abstract": "<jats:title>Abstract</jats:title>\n<jats:p>The role of GLP-1 agonists in the treatment of type 2 diabetes have been shown to be viable options for add-on therapy in diabetic patients, as well as potential monotherapy options. With six available GLP-1 agents, and new combination products in the pipeline, they are a promising drug class for type 2 diabetic patients, especially due to their extended dosing interval and potential weight loss benefits.</jats:p>", "DOI": "10.1515/jtim-2017-0015", "type": "journal-article", "created": {"date-parts": [[2017, 7, 3]], "date-time": "2017-07-03T08:08:10Z", "timestamp": 1499069290000}, "page": "79-89", "source": "Crossref", "is-referenced-by-count": 4, "title": ["The role of glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes"], "prefix": "10.1515", "volume": "5", "author": [{"given": "Erin", "family": "St Onge", "sequence": "first", "affiliation": []}, {"given": "Shannon", "family": "Miller", "sequence": "additional", "affiliation": []}, {"given": "Elizabeth", "family": "Clements", "sequence": "additional", "affiliation": []}, {"given": "Lindsay", "family": "Celauro", "sequence": "additional", "affiliation": []}, {"given": "Ke\u2019la", "family": "Barnes", "sequence": "additional", "affiliation": []}], "member": "374", "reference": [{"key": "ref431", "volume": "3", "first-page": "70", "year": "2012", "article-title": "Comparison of incretin immunoassays with or without plasma extraction: incretin secretion in Japanese patients with type 2 diabetes", "journal-title": "J Diabetes Invest", "DOI": "10.1111/j.2040-1124.2011.00141.x", "doi-asserted-by": "crossref"}, {"key": "ref1001", "volume": "384", "first-page": "2228", "year": "2014", "article-title": "Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis", "journal-title": "The Lancet", "DOI": "10.1016/S0140-6736(14)61335-0", "doi-asserted-by": "crossref"}, {"key": "ref321", "volume": "384", "first-page": "1349", "year": "2014", "article-title": "Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomized, open-label, phase 3, non-inferiority trial", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(14)60976-4", "doi-asserted-by": "crossref"}, {"key": "ref571", "volume": "36", "first-page": "293", "year": "2016", "article-title": "Type 2 diabetes patients reach target glycemic control faster using IDegLira than either insulin degludec or liraglutide given alone", "journal-title": "Clin Drug Investig", "DOI": "10.1007/s40261-016-0376-0", "doi-asserted-by": "crossref"}, {"key": "ref471", "volume": "13", "first-page": "592", "year": "2011", "article-title": "The effect of liraglutide added to U-500 insulin in patients with type 2 diabetes and high insulin requirements", "journal-title": "Diabet Tech Ther", "DOI": "10.1089/dia.2010.0221", "doi-asserted-by": "crossref"}, {"key": "ref1121", "volume": "315", "first-page": "898", "year": "2016", "article-title": "Effect of insulin glargine up-titration vs insulin degludec/liraglutide on glycated hemoglobin levels in patients with uncontrolled type 2 diabetes", "journal-title": "JAMA", "DOI": "10.1001/jama.2016.1252", "doi-asserted-by": "crossref"}, {"key": "ref1131", "volume": "37", "first-page": "2926", "year": "2014", "article-title": "Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc14-0785", "doi-asserted-by": "crossref"}, {"key": "ref41", "volume": "47", "first-page": "357", "year": "2004", "article-title": "Incretins, insulin secretion and type 2 diabetes mellitus", "journal-title": "Diabetologia", "DOI": "10.1007/s00125-004-1342-6", "doi-asserted-by": "crossref"}, {"key": "ref501", "volume": "39", "first-page": "1318", "year": "2016", "article-title": "Prandial options to advance basal insulin glargine therapy: testing lixisenatide plus basal insulin versus insulin glulisine either as basal-plus or basal-bolus in type 2 diabetes: the GetGoal Duo-2 Trial", "journal-title": "Diabetes Care", "DOI": "10.2337/dc16-0014", "doi-asserted-by": "crossref"}, {"key": "ref191", "volume": "50", "first-page": "259", "year": "2007", "article-title": "A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study", "journal-title": "Diabetologia", "DOI": "10.1007/s00125-006-0510-2", "doi-asserted-by": "crossref"}, {"key": "ref811", "volume": "123", "first-page": "e9", "year": "2010", "article-title": "Effects of exenatide combined with lifestyle modification in patients with type 2 diabetes", "journal-title": "Am J Med"}, {"key": "ref851", "volume": "32", "first-page": "1224", "year": "2009", "article-title": "Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc08-2124", "doi-asserted-by": "crossref"}, {"key": "ref221", "volume": "27", "first-page": "2628", "year": "2004", "article-title": "Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes", "journal-title": "Diabetes Care", "DOI": "10.2337/diacare.27.11.2628", "doi-asserted-by": "crossref"}, {"key": "ref761", "volume": "34", "first-page": "604", "year": "2011", "article-title": "Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type 2 diabetes", "journal-title": "Diabetes Care", "DOI": "10.2337/dc10-1900", "doi-asserted-by": "crossref"}, {"key": "ref911", "volume": "37", "first-page": "2149", "year": "2014", "article-title": "Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc13-2761", "doi-asserted-by": "crossref"}, {"key": "ref881", "volume": "37", "first-page": "2141", "year": "2014", "article-title": "Harmony 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin", "journal-title": "Diabetes Care", "DOI": "10.2337/dc14-0024", "doi-asserted-by": "crossref"}, {"key": "ref51", "volume": "122", "first-page": "S3", "year": "2009", "article-title": "Unraveling the science of incretin biology", "journal-title": "Am J Med", "DOI": "10.1016/j.amjmed.2009.03.012", "doi-asserted-by": "crossref"}, {"key": "ref21", "volume": "121", "first-page": "53", "year": "2011", "article-title": "Focus on Incretin-Based Therapies: Targeting the Core Defects of Type 2 Diabetes", "journal-title": "Postgrad Med"}, {"key": "ref921", "volume": "384", "first-page": "1349", "year": "2014", "article-title": "Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomized, open-label, phase 3, non-inferiority trial", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(14)60976-4", "doi-asserted-by": "crossref"}, {"key": "ref391", "volume": "36", "first-page": "S226", "year": "2013", "article-title": "Combining incretin-based therapies with insulin", "journal-title": "Diabetes Care", "DOI": "10.2337/dcS13-2036", "doi-asserted-by": "crossref"}, {"key": "ref831", "volume": "12", "first-page": "1058", "year": "2010", "article-title": "A placebo-controlled trial of exenatide twice-daily added to thiazolidinediones alone or in combination with metformin", "journal-title": "Diabetes Obes Metab", "DOI": "10.1111/j.1463-1326.2010.01251.x", "doi-asserted-by": "crossref"}, {"key": "ref941", "volume": "36", "first-page": "2543", "year": "2013", "article-title": "Efficacy and safety of lixisenatide once-daily morning or evening injections in type 2 diabetes inadequately controlled on metformin (GetGoal-M)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc12-2006", "doi-asserted-by": "crossref"}, {"key": "ref231", "volume": "12", "first-page": "1058", "year": "2010", "article-title": "A placebo-controlled trial of exenatide twice-daily added to thiazolidinediones alone or in combination with metformin", "journal-title": "Diabetes Obes Metab", "DOI": "10.1111/j.1463-1326.2010.01251.x", "doi-asserted-by": "crossref"}, {"key": "ref751", "volume": "666", "first-page": "251", "year": "2011", "article-title": "Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients", "journal-title": "Eur J Pharmacol", "DOI": "10.1016/j.ejphar.2011.05.051", "doi-asserted-by": "crossref"}, {"key": "ref581", "year": "2017", "article-title": "LAPS CA-Exendin-4 (efpeglenatide) enhances insulin secretion and beta cell responsiveness in subjects with type 2 diabetes. Poster presented at European Association for the Study of Diabetes (EASD) 51st Annual Meeting", "journal-title": "Stockholm, Sweden; 2015 Sept"}, {"key": "ref901", "volume": "56", "first-page": "S360", "year": "2013", "article-title": "HARMONY 4: 52-week efficacy of albiglutide vs insulin glargine in patients with type 2 diabetes mellitus", "journal-title": "Diabetologia"}, {"key": "ref441", "volume": "36", "first-page": "2497", "year": "2013", "article-title": "Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc12-2462", "doi-asserted-by": "crossref"}, {"key": "ref1021", "volume": "14", "first-page": "910", "year": "2012", "article-title": "Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)", "journal-title": "Diabetes Obes Metab", "DOI": "10.1111/j.1463-1326.2012.01618.x", "doi-asserted-by": "crossref"}, {"key": "ref291", "volume": "56", "first-page": "S361", "year": "2013", "article-title": "52-week efficacy of albiglutide vs placebo and vs pioglitazone in triple therapy (background metformin and glimepiride) in patients with type 2 diabetes: HARMONY 5 study", "journal-title": "Diabetologia"}, {"key": "ref931", "volume": "37", "first-page": "2159", "year": "2014", "article-title": "Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD-1)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc13-2760", "doi-asserted-by": "crossref"}, {"key": "ref181", "volume": "143", "first-page": "559", "year": "2005", "article-title": "Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes", "journal-title": "Annals of Internal Medicine", "DOI": "10.7326/0003-4819-143-8-200510180-00006", "doi-asserted-by": "crossref"}, {"key": "ref311", "volume": "37", "first-page": "2149", "year": "2014", "article-title": "Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc13-2761", "doi-asserted-by": "crossref"}, {"key": "ref451", "volume": "31", "first-page": "1511", "year": "2009", "article-title": "Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting", "journal-title": "Clin Ther", "DOI": "10.1016/j.clinthera.2009.07.021", "doi-asserted-by": "crossref"}, {"key": "ref1111", "volume": "16", "first-page": "636", "year": "2014", "article-title": "A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)", "journal-title": "Diabetes Obes Metab", "DOI": "10.1111/dom.12262", "doi-asserted-by": "crossref"}, {"key": "ref1091", "volume": "37", "first-page": "2763", "year": "2014", "article-title": "Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes", "journal-title": "Diabetes Care", "DOI": "10.2337/dc14-0876", "doi-asserted-by": "crossref"}, {"key": "ref1151", "volume": "39", "first-page": "1579", "year": "2016", "article-title": "Efficacy and safety of LixiLan, a titratable fixed-ration combination of lixisenatide and insulin glargine, versus insulin glargine in type 2 diabetes inadequately controlled on metformin monotherapy: the LixiLan proof-of-concept randomized trial", "journal-title": "Diabetes Care", "DOI": "10.2337/dc16-0046", "doi-asserted-by": "crossref"}, {"key": "ref861", "volume": "52", "first-page": "2046", "year": "2009", "article-title": "Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomized controlled trial", "journal-title": "Diabetologia", "DOI": "10.1007/s00125-009-1472-y", "doi-asserted-by": "crossref"}, {"key": "ref621", "volume": "121", "first-page": "53", "year": "2011", "article-title": "Focus on Incretin-Based Therapies: Targeting the Core Defects of Type 2 Diabetes", "journal-title": "Postgrad Med"}, {"key": "ref641", "volume": "47", "first-page": "357", "year": "2004", "article-title": "Incretins, insulin secretion and type 2 diabetes mellitus", "journal-title": "Diabetologia", "DOI": "10.1007/s00125-004-1342-6", "doi-asserted-by": "crossref"}, {"key": "ref981", "volume": "36", "first-page": "893", "year": "2016", "article-title": "GLP1-RA add-on therapy in patients with type 2 diabetes currently on a bolus containing insulin regimen", "journal-title": "Pharmacotherapy", "DOI": "10.1002/phar.1792", "doi-asserted-by": "crossref"}, {"key": "ref361", "volume": "28", "first-page": "386", "year": "2014", "article-title": "Beneficial effects of once-daily lixisenatide on overall and post-prandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)", "journal-title": "J Diabetes Complicat", "DOI": "10.1016/j.jdiacomp.2014.01.012", "doi-asserted-by": "crossref"}, {"key": "ref531", "volume": "37", "first-page": "2926", "year": "2014", "article-title": "Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc14-0785", "doi-asserted-by": "crossref"}, {"key": "ref1051", "volume": "31", "first-page": "1511", "year": "2009", "article-title": "Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting", "journal-title": "Clin Ther", "DOI": "10.1016/j.clinthera.2009.07.021", "doi-asserted-by": "crossref"}, {"key": "ref1171", "volume": "36", "first-page": "293", "year": "2016", "article-title": "Type 2 diabetes patients reach target glycemic control faster using IDegLira than either insulin degludec or liraglutide given alone", "journal-title": "Clin Drug Investig", "DOI": "10.1007/s40261-016-0376-0", "doi-asserted-by": "crossref"}, {"key": "ref161", "volume": "34", "first-page": "604", "year": "2011", "article-title": "Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type 2 diabetes", "journal-title": "Diabetes Care", "DOI": "10.2337/dc10-1900", "doi-asserted-by": "crossref"}, {"key": "ref281", "volume": "37", "first-page": "2141", "year": "2014", "article-title": "Harmony 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin", "journal-title": "Diabetes Care", "DOI": "10.2337/dc14-0024", "doi-asserted-by": "crossref"}, {"key": "ref171", "volume": "28", "first-page": "1083", "year": "2005", "article-title": "Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea", "journal-title": "Diabetes Care", "DOI": "10.2337/diacare.28.5.1083", "doi-asserted-by": "crossref"}, {"key": "ref951", "volume": "36", "first-page": "2945", "year": "2013", "article-title": "Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc12-2709", "doi-asserted-by": "crossref"}, {"key": "ref541", "volume": "6", "first-page": "573", "year": "2015", "article-title": "IDegLira versus alternative intensification strategies in patients with type 2 diabetes inadequately controlled on basal insulin therapy", "journal-title": "Diabetes Ther", "DOI": "10.1007/s13300-015-0142-y", "doi-asserted-by": "crossref"}, {"key": "ref891", "volume": "56", "first-page": "S361", "year": "2013", "article-title": "52-week efficacy of albiglutide vs placebo and vs pioglitazone in triple therapy (background metformin and glimepiride) in patients with type 2 diabetes: HARMONY 5 study", "journal-title": "Diabetologia"}, {"key": "ref141", "volume": "12", "first-page": "233", "year": "2010", "article-title": "Exenatide versus glibenclamide in patients with diabetes", "journal-title": "Diabetes Technol Therapeut", "DOI": "10.1089/dia.2009.0141", "doi-asserted-by": "crossref"}, {"key": "ref841", "volume": "65", "first-page": "397", "year": "2011", "article-title": "One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomized, parallel-group, open-label trial", "journal-title": "Int J Clin Pract", "DOI": "10.1111/j.1742-1241.2011.02656.x", "doi-asserted-by": "crossref"}, {"key": "ref1061", "volume": "6", "first-page": "41", "year": "2012", "article-title": "Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction", "journal-title": "Prim Care Diabetes", "DOI": "10.1016/j.pcd.2011.09.002", "doi-asserted-by": "crossref"}, {"key": "ref251", "volume": "32", "first-page": "1224", "year": "2009", "article-title": "Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc08-2124", "doi-asserted-by": "crossref"}, {"key": "ref351", "volume": "36", "first-page": "2945", "year": "2013", "article-title": "Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc12-2709", "doi-asserted-by": "crossref"}, {"key": "ref1011", "volume": "154", "first-page": "103", "year": "2011", "article-title": "Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes", "journal-title": "Ann of Int Med", "DOI": "10.7326/0003-4819-154-2-201101180-00300", "doi-asserted-by": "crossref"}, {"key": "ref271", "volume": "26", "first-page": "268", "year": "2009", "article-title": "Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)", "journal-title": "Diabetic Med", "DOI": "10.1111/j.1464-5491.2009.02666.x", "doi-asserted-by": "crossref"}, {"key": "ref131", "volume": "28", "first-page": "1092", "year": "2005", "article-title": "Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes", "journal-title": "Diabetes Care", "DOI": "10.2337/diacare.28.5.1092", "doi-asserted-by": "crossref"}, {"key": "ref961", "volume": "28", "first-page": "386", "year": "2014", "article-title": "Beneficial effects of once-daily lixisenatide on overall and post-prandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)", "journal-title": "J Diabetes Complicat", "DOI": "10.1016/j.jdiacomp.2014.01.012", "doi-asserted-by": "crossref"}, {"key": "ref1161", "year": "September 2016", "journal-title": "FDA extends regulatory review period for IDegLira by three months"}, {"key": "ref61", "volume": "31", "first-page": "289", "year": "2014", "article-title": "Incorporating incretin-based therapies into clinical practice for patients with type 2 diabetes", "journal-title": "Adv Ther", "DOI": "10.1007/s12325-014-0100-5", "doi-asserted-by": "crossref"}, {"key": "ref701", "author": "Byetta", "year": "2009", "article-title": "exenatide package insert San CA Pharmaceuticals"}, {"key": "ref261", "volume": "52", "first-page": "2046", "year": "2009", "article-title": "Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomized controlled trial", "journal-title": "Diabetologia", "DOI": "10.1007/s00125-009-1472-y", "doi-asserted-by": "crossref"}, {"key": "ref521", "volume": "315", "first-page": "898", "year": "2016", "article-title": "Effect of insulin glargine up-titration vs insulin degludec/liraglutide on glycated hemoglobin levels in patients with uncontrolled type 2 diabetes", "journal-title": "JAMA", "DOI": "10.1001/jama.2016.1252", "doi-asserted-by": "crossref"}, {"key": "ref731", "volume": "28", "first-page": "1092", "year": "2005", "article-title": "Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes", "journal-title": "Diabetes Care", "DOI": "10.2337/diacare.28.5.1092", "doi-asserted-by": "crossref"}, {"key": "ref791", "volume": "50", "first-page": "259", "year": "2007", "article-title": "A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study", "journal-title": "Diabetologia", "DOI": "10.1007/s00125-006-0510-2", "doi-asserted-by": "crossref"}, {"key": "ref401", "volume": "384", "first-page": "2228", "year": "2014", "article-title": "Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis", "journal-title": "The Lancet", "DOI": "10.1016/S0140-6736(14)61335-0", "doi-asserted-by": "crossref"}, {"key": "ref211", "volume": "123", "first-page": "e9", "year": "2010", "article-title": "Effects of exenatide combined with lifestyle modification in patients with type 2 diabetes", "journal-title": "Am J Med"}, {"key": "ref151", "volume": "666", "first-page": "251", "year": "2011", "article-title": "Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients", "journal-title": "Eur J Pharmacol", "DOI": "10.1016/j.ejphar.2011.05.051", "doi-asserted-by": "crossref"}, {"key": "ref411", "volume": "154", "first-page": "103", "year": "2011", "article-title": "Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes", "journal-title": "Ann of Int Med", "DOI": "10.7326/0003-4819-154-2-201101180-00300", "doi-asserted-by": "crossref"}, {"key": "ref991", "volume": "36", "first-page": "S226", "year": "2013", "article-title": "Combining incretin-based therapies with insulin", "journal-title": "Diabetes Care", "DOI": "10.2337/dcS13-2036", "doi-asserted-by": "crossref"}, {"key": "ref371", "volume": "15", "first-page": "1000", "year": "2013", "article-title": "Efficacy and Safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone (GetGoal-P)", "journal-title": "Diabetes Obes Metab", "DOI": "10.1111/dom.12121", "doi-asserted-by": "crossref"}, {"key": "ref1071", "volume": "13", "first-page": "592", "year": "2011", "article-title": "The effect of liraglutide added to U-500 insulin in patients with type 2 diabetes and high insulin requirements", "journal-title": "Diabet Tech Ther", "DOI": "10.1089/dia.2010.0221", "doi-asserted-by": "crossref"}, {"key": "ref241", "volume": "65", "first-page": "397", "year": "2011", "article-title": "One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomized, parallel-group, open-label trial", "journal-title": "Int J Clin Pract", "DOI": "10.1111/j.1742-1241.2011.02656.x", "doi-asserted-by": "crossref"}, {"key": "ref561", "year": "September 2016", "journal-title": "FDA extends regulatory review period for IDegLira by three months"}, {"key": "ref821", "volume": "27", "first-page": "2628", "year": "2004", "article-title": "Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes", "journal-title": "Diabetes Care", "DOI": "10.2337/diacare.27.11.2628", "doi-asserted-by": "crossref"}, {"key": "ref1181", "year": "2017", "article-title": "LAPS CA-Exendin-4 (efpeglenatide) enhances insulin secretion and beta cell responsiveness in subjects with type 2 diabetes. Poster presented at European Association for the Study of Diabetes (EASD) 51st Annual Meeting", "journal-title": "Stockholm, Sweden; 2015 Sept"}, {"key": "ref491", "volume": "37", "first-page": "2763", "year": "2014", "article-title": "Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes", "journal-title": "Diabetes Care", "DOI": "10.2337/dc14-0876", "doi-asserted-by": "crossref"}, {"key": "ref481", "volume": "37", "first-page": "2317", "year": "2014", "article-title": "Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro", "journal-title": "Diabetes Care", "DOI": "10.2337/dc14-0001", "doi-asserted-by": "crossref"}, {"key": "ref871", "volume": "26", "first-page": "268", "year": "2009", "article-title": "Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)", "journal-title": "Diabetic Med", "DOI": "10.1111/j.1464-5491.2009.02666.x", "doi-asserted-by": "crossref"}, {"key": "ref301", "volume": "56", "first-page": "S360", "year": "2013", "article-title": "HARMONY 4: 52-week efficacy of albiglutide vs insulin glargine in patients with type 2 diabetes mellitus", "journal-title": "Diabetologia"}, {"key": "ref971", "volume": "15", "first-page": "1000", "year": "2013", "article-title": "Efficacy and Safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone (GetGoal-P)", "journal-title": "Diabetes Obes Metab", "DOI": "10.1111/dom.12121", "doi-asserted-by": "crossref"}, {"key": "ref651", "volume": "122", "first-page": "S3", "year": "2009", "article-title": "Unraveling the science of incretin biology", "journal-title": "Am J Med", "DOI": "10.1016/j.amjmed.2009.03.012", "doi-asserted-by": "crossref"}, {"key": "ref381", "volume": "36", "first-page": "893", "year": "2016", "article-title": "GLP1-RA add-on therapy in patients with type 2 diabetes currently on a bolus containing insulin regimen", "journal-title": "Pharmacotherapy", "DOI": "10.1002/phar.1792", "doi-asserted-by": "crossref"}, {"key": "ref101", "author": "Byetta", "year": "2009", "article-title": "exenatide package insert San CA Pharmaceuticals"}, {"key": "ref1101", "volume": "39", "first-page": "1318", "year": "2016", "article-title": "Prandial options to advance basal insulin glargine therapy: testing lixisenatide plus basal insulin versus insulin glulisine either as basal-plus or basal-bolus in type 2 diabetes: the GetGoal Duo-2 Trial", "journal-title": "Diabetes Care", "DOI": "10.2337/dc16-0014", "doi-asserted-by": "crossref"}, {"key": "ref421", "volume": "14", "first-page": "910", "year": "2012", "article-title": "Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)", "journal-title": "Diabetes Obes Metab", "DOI": "10.1111/j.1463-1326.2012.01618.x", "doi-asserted-by": "crossref"}, {"key": "ref661", "volume": "31", "first-page": "289", "year": "2014", "article-title": "Incorporating incretin-based therapies into clinical practice for patients with type 2 diabetes", "journal-title": "Adv Ther", "DOI": "10.1007/s12325-014-0100-5", "doi-asserted-by": "crossref"}, {"key": "ref801", "volume": "11", "first-page": "1153", "year": "2009", "article-title": "Exenatide compared with long-acting insulin to achieve glycemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study", "journal-title": "Diabetes Obes Metab", "DOI": "10.1111/j.1463-1326.2009.01154.x", "doi-asserted-by": "crossref"}, {"key": "ref551", "volume": "39", "first-page": "1579", "year": "2016", "article-title": "Efficacy and safety of LixiLan, a titratable fixed-ration combination of lixisenatide and insulin glargine, versus insulin glargine in type 2 diabetes inadequately controlled on metformin monotherapy: the LixiLan proof-of-concept randomized trial", "journal-title": "Diabetes Care", "DOI": "10.2337/dc16-0046", "doi-asserted-by": "crossref"}, {"key": "ref201", "volume": "11", "first-page": "1153", "year": "2009", "article-title": "Exenatide compared with long-acting insulin to achieve glycemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study", "journal-title": "Diabetes Obes Metab", "DOI": "10.1111/j.1463-1326.2009.01154.x", "doi-asserted-by": "crossref"}, {"key": "ref331", "volume": "37", "first-page": "2159", "year": "2014", "article-title": "Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD-1)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc13-2760", "doi-asserted-by": "crossref"}, {"key": "ref511", "volume": "16", "first-page": "636", "year": "2014", "article-title": "A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)", "journal-title": "Diabetes Obes Metab", "DOI": "10.1111/dom.12262", "doi-asserted-by": "crossref"}, {"key": "ref1081", "volume": "37", "first-page": "2317", "year": "2014", "article-title": "Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro", "journal-title": "Diabetes Care", "DOI": "10.2337/dc14-0001", "doi-asserted-by": "crossref"}, {"key": "ref781", "volume": "143", "first-page": "559", "year": "2005", "article-title": "Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes", "journal-title": "Annals of Internal Medicine", "DOI": "10.7326/0003-4819-143-8-200510180-00006", "doi-asserted-by": "crossref"}, {"key": "ref771", "volume": "28", "first-page": "1083", "year": "2005", "article-title": "Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea", "journal-title": "Diabetes Care", "DOI": "10.2337/diacare.28.5.1083", "doi-asserted-by": "crossref"}, {"key": "ref1041", "volume": "36", "first-page": "2497", "year": "2013", "article-title": "Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc12-2462", "doi-asserted-by": "crossref"}, {"key": "ref461", "volume": "6", "first-page": "41", "year": "2012", "article-title": "Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction", "journal-title": "Prim Care Diabetes", "DOI": "10.1016/j.pcd.2011.09.002", "doi-asserted-by": "crossref"}, {"key": "ref1031", "volume": "3", "first-page": "70", "year": "2012", "article-title": "Comparison of incretin immunoassays with or without plasma extraction: incretin secretion in Japanese patients with type 2 diabetes", "journal-title": "J Diabetes Invest", "DOI": "10.1111/j.2040-1124.2011.00141.x", "doi-asserted-by": "crossref"}, {"key": "ref341", "volume": "36", "first-page": "2543", "year": "2013", "article-title": "Efficacy and safety of lixisenatide once-daily morning or evening injections in type 2 diabetes inadequately controlled on metformin (GetGoal-M)", "journal-title": "Diabetes Care", "DOI": "10.2337/dc12-2006", "doi-asserted-by": "crossref"}, {"key": "ref741", "volume": "12", "first-page": "233", "year": "2010", "article-title": "Exenatide versus glibenclamide in patients with diabetes", "journal-title": "Diabetes Technol Therapeut", "DOI": "10.1089/dia.2009.0141", "doi-asserted-by": "crossref"}, {"key": "ref1141", "volume": "6", "first-page": "573", "year": "2015", "article-title": "IDegLira versus alternative intensification strategies in patients with type 2 diabetes inadequately controlled on basal insulin therapy", "journal-title": "Diabetes Ther", "DOI": "10.1007/s13300-015-0142-y", "doi-asserted-by": "crossref"}], "container-title": ["Journal of Translational Internal Medicine"], "link": [{"URL": "http://content.sciendo.com/view/journals/jtim/5/2/article-p79.xml", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.degruyter.com/view/j/jtim.2017.5.issue-2/jtim-2017-0015/jtim-2017-0015.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 9, 2]], "date-time": "2018-09-02T01:30:49Z", "timestamp": 1535851849000}, "score": 18.698376, "issued": {"date-parts": [[2017, 6, 30]]}, "references-count": 102, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.1515/jtim-2017-0015", "relation": {"cites": []}, "ISSN": ["2224-4018"], "issn-type": [{"value": "2224-4018", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T07:29:11Z", "timestamp": 1574148551258}, "reference-count": 0, "publisher": "CSIRO Publishing", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Aust. J.  Agric. Res."], "published-print": {"date-parts": [[1973]]}, "abstract": "<jats:p> Seedling growth of half-sib families from two lines of P. tuberosa previously selected for high and low herbage nitrogen contents respectively was examined in a glasshouse during the autumn and winter. Seedlings from the high nitrogen line were smaller than those of the low nitrogen line but had similar whole-plant relative growth rates. Differences in the rate of nitrogen absorption by the roots (h), and in the rate of seedling weight increase per unit of absorbed nitrogen (EN), accounted for most of the variation in herbage nitrogen content between families. The heights of seedlings were closely correlated with the weights of seeds from which they originated and with EN, and when these two characters were held constant the partial correlation between nitrogen content and seedling weight was negligible (r = -0.05). Among 10 clones differing markedly in herbage nitrogen content in the field, seed weight was closely correlated with the photosynthetic area above the flag leaf node available to each seed, particularly that contributed by the spikelet (r = 0.82***). Two alternative interpretations of this result are discussed. Relationships between nitrogen content, spikelet number, and the areas of photosynthesizing organs above the flag leaf node suggest that seed weight could be maintained during selection for increased nitrogen content by concurrently selecting either for large seeds, or for large flag leaves and a reduced number of spikelets per head. Even so, some loss of actual or potentially attainable seedling vigour seems almost inevitable because of the dependence of nitrogen content on IN and EN and because EN is an important determinant of vigour. </jats:p>", "DOI": "10.1071/ar9730047", "type": "journal-article", "created": {"date-parts": [[2004, 11, 17]], "date-time": "2004-11-17T20:58:57Z", "timestamp": 1100725137000}, "page": "47", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Selection for crude protein content in Phalaris tuberosa L. III. Physiological relationships between crude protein content and seedling vigour."], "prefix": "10.1071", "volume": "24", "author": [{"given": "RJ", "family": "Clements", "sequence": "first", "affiliation": []}], "member": "67", "container-title": ["Australian Journal of Agricultural Research"], "language": "en", "link": [{"URL": "http://www.publish.csiro.au/AR/pdf/AR9730047", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 21]], "date-time": "2018-11-21T04:20:52Z", "timestamp": 1542774052000}, "score": 18.316069, "issued": {"date-parts": [[1973]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1973]]}, "issue": "1"}, "alternative-id": ["AR9730047"], "URL": "http://dx.doi.org/10.1071/ar9730047", "ISSN": ["0004-9409"], "issn-type": [{"value": "0004-9409", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T18:32:28Z", "timestamp": 1575397948785}, "reference-count": 136, "publisher": "Elsevier", "isbn-type": [{"value": "9781483166940", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1949]]}, "DOI": "10.1016/b978-1-4831-6694-0.50006-8", "type": "book-chapter", "created": {"date-parts": [[2013, 11, 19]], "date-time": "2013-11-19T05:11:33Z", "timestamp": 1384837893000}, "page": "10-39", "source": "Crossref", "is-referenced-by-count": 0, "title": ["F\u0152TAL NUTRITION\u2014CARBOHYDRATE, PROTEIN, FAT, AND MINERALS"], "prefix": "10.1016", "author": [{"given": "F.W.", "family": "CLEMENTS", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Infant Nutrition"], "deposited": {"date-parts": [[2019, 8, 2]], "date-time": "2019-08-02T12:58:28Z", "timestamp": 1564750708000}, "score": 18.230873, "issued": {"date-parts": [[1949]]}, "ISBN": ["9781483166940"], "references-count": 136, "URL": "http://dx.doi.org/10.1016/b978-1-4831-6694-0.50006-8"}, {"institution": {"name": "bioRxiv", "place": ["-"], "acronym": ["-"]}, "indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T19:14:17Z", "timestamp": 1576869257775}, "posted": {"date-parts": [[2019, 12, 13]]}, "group-title": "Neuroscience", "reference-count": 47, "publisher": "Cold Spring Harbor Laboratory", "content-domain": {"domain": [], "crossmark-restriction": false}, "accepted": {"date-parts": [[2019, 12, 18]]}, "abstract": "<jats:title>Abstract</jats:title><jats:p>Neuronal circuits can be re-modeled by Hebbian plasticity, synaptic scaling and, under some circumstances, activity-dependent respecification of cell-surface receptors. Although the impact of sleep on Hebbian plasticity and synaptic scaling are well studied, sleep\u2019s role in receptor respecification remains unclear. We demonstrate that high sleep-pressure quickly reprograms the <jats:italic>Drosophila</jats:italic> wake-promoting large-ventrolateral clock-neurons to express the Pigment Dispersing Factor receptor. The addition of this signaling input into the circuit is associated with increased waking and early mating success. The respecification of Pigment Dispersing Factor receptor in both young and adult large ventrolateral neurons requires two dopamine receptors and activation of the transcriptional regulator <jats:italic>nejire</jats:italic> (CREB-binding protein). These data identify receptor-respecification as an important mechanism to sculpt circuit function to match sleep levels with demand.</jats:p>", "DOI": "10.1101/2019.12.12.874628", "type": "posted-content", "created": {"date-parts": [[2019, 12, 13]], "date-time": "2019-12-13T20:25:10Z", "timestamp": 1576268710000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Sleep-drive reprograms clock neuronal identity through CREB-binding protein induced PDFR expression"], "prefix": "10.1101", "author": [{"given": "MK", "family": "Klose", "sequence": "first", "affiliation": []}, {"given": "PJ", "family": "Shaw", "sequence": "additional", "affiliation": []}], "member": "246", "reference": [{"key": "2019122010350887000_2019.12.12.874628v3.1", "DOI": "10.1016/j.neuron.2015.05.028", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.2", "DOI": "10.1126/science.1234152", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.3", "DOI": "10.1146/annurev-neuro-072116-031204", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.4", "DOI": "10.1126/science.152.3722.604", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.5", "DOI": "10.1126/science.1220939", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.6", "DOI": "10.1016/j.physbeh.2017.08.020", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.7", "DOI": "10.1371/journal.pbio.1000466", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.8", "DOI": "10.1038/nrn2697", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.9", "DOI": "10.1016/j.neuron.2017.06.001", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.10", "DOI": "10.7554/eLife.19837", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.11", "DOI": "10.1126/science.287.5459.1834", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.12", "DOI": "10.7554/eLife.27445", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.13", "DOI": "10.1126/science.1166657", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.14", "DOI": "10.1016/j.cub.2010.05.029", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.15", "DOI": "10.1016/S0092-8674(00)81676-1", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.16", "DOI": "10.1073/pnas.0809577105", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.17", "DOI": "10.1523/JNEUROSCI.20-09-03339.2000", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.18", "DOI": "10.1016/j.cub.2018.04.064", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.19", "DOI": "10.1016/j.cub.2019.08.033", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.20", "DOI": "10.1016/j.neuron.2016.04.002", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.21", "DOI": "10.1101/lm.4.2.219", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.22", "DOI": "10.1093/sleep/34.2.137", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.23", "DOI": "10.1126/science.1250553", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.24", "DOI": "10.1016/j.neuron.2008.02.018", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.25", "DOI": "10.1038/nn.2860", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.26", "DOI": "10.1002/cne.22311", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.27", "DOI": "10.1016/j.cub.2008.07.028", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.28", "DOI": "10.1371/journal.pgen.1006346", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.29", "DOI": "10.1371/journal.pone.0001896", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.30", "DOI": "10.1038/nature02926", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.31", "DOI": "10.1016/j.neuron.2013.09.034", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.32", "DOI": "10.1038/s41598-017-08155-y", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.33", "DOI": "10.1371/journal.pone.0001391", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.34", "DOI": "10.1073/pnas.1112623109", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.35", "DOI": "10.1126/science.1202249", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.36", "DOI": "10.1016/j.cub.2015.03.027", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.37", "DOI": "10.1016/S0896-6273(00)80877-6", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.38", "DOI": "10.1073/pnas.1002081107", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.39", "DOI": "10.1038/s41467-017-00087-5", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.40", "DOI": "10.1098/rstb.2016.0258", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.41", "DOI": "10.1016/j.cub.2015.10.006", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.42", "unstructured": "Thimgan, M. S. , Seugnet, L. , Turk, J. & Shaw, P. J. Identification of Genes Associated With Resilience/Vulnerability to Sleep Deprivation and Starvation in. Sleep (2014).", "DOI": "10.5665/sleep.4680", "doi-asserted-by": "crossref"}, {"key": "2019122010350887000_2019.12.12.874628v3.43", "DOI": "10.1146/annurev.neuro.24.1.429", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.44", "DOI": "10.1016/j.cub.2012.09.008", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.45", "DOI": "10.1074/jbc.M702319200", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.46", "DOI": "10.3389/fnsys.2014.00043", "doi-asserted-by": "publisher"}, {"key": "2019122010350887000_2019.12.12.874628v3.47", "DOI": "10.1038/417287a", "doi-asserted-by": "publisher"}], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1101/2019.12.12.874628", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T18:35:18Z", "timestamp": 1576866918000}, "score": 17.908514, "issued": {"date-parts": [[2019, 12, 13]]}, "references-count": 47, "URL": "http://dx.doi.org/10.1101/2019.12.12.874628", "relation": {"cites": []}, "subtype": "preprint"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T07:35:48Z", "timestamp": 1574148948428}, "reference-count": 78, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4628, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Dev. Dyn."], "published-print": {"date-parts": [[2003, 1]]}, "DOI": "10.1002/dvdy.10209", "type": "journal-article", "created": {"date-parts": [[2003, 1, 1]], "date-time": "2003-01-01T02:22:45Z", "timestamp": 1041387765000}, "page": "67-81", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Drosophila NAB (dNAB) is an orphan transcriptional co-repressor required for correct CNS and eye development"], "prefix": "10.1002", "volume": "226", "author": [{"given": "Mark", "family": "Clements", "sequence": "first", "affiliation": []}, {"given": "Dianne", "family": "Duncan", "sequence": "additional", "affiliation": []}, {"given": "Jeffrey", "family": "Milbrandt", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2002, 12, 30]]}, "reference": [{"key": "BIB1", "author": "Ausubel", "year": "2001", "unstructured": "2001. Current protocols in molecular biology. New York: John Wiley & Sons.", "volume-title": "Current protocols in molecular biology", "DOI": "10.1002/0471142727", "doi-asserted-by": "crossref"}, {"key": "BIB2", "author": "Bellone", "volume": "14", "first-page": "353", "year": "1999", "journal-title": "Hum Mutat", "DOI": "10.1002/(SICI)1098-1004(199910)14:4<353::AID-HUMU17>3.0.CO;2-4", "doi-asserted-by": "crossref"}, {"key": "BIB3", "author": "Boquet", "volume": "42", "first-page": "33", "year": "2000", "journal-title": "J Neurobiol", "DOI": "10.1002/(SICI)1097-4695(200001)42:1<33::AID-NEU4>3.0.CO;2-T", "doi-asserted-by": "crossref"}, {"key": "BIB4", "author": "Bossing", "volume": "179", "first-page": "41", "year": "1996", "journal-title": "Dev Biol", "DOI": "10.1006/dbio.1996.0240", "doi-asserted-by": "crossref"}, {"key": "BIB5", "author": "Botti", "volume": "63", "first-page": "a352", "year": "1998", "journal-title": "Am J Hum Genet"}, {"key": "BIB6", "author": "Brand", "volume": "118", "first-page": "401", "year": "1993", "journal-title": "Development"}, {"key": "BIB7", "author": "Brantjes", "volume": "29", "first-page": "1410", "year": "2001", "journal-title": "Nucleic Acids Res", "DOI": "10.1093/nar/29.7.1410", "doi-asserted-by": "crossref"}, {"key": "BIB8", "author": "Broadus", "volume": "53", "first-page": "393", "year": "1995", "journal-title": "Mech Dev", "DOI": "10.1016/0925-4773(95)00454-8", "doi-asserted-by": "crossref"}, {"key": "BIB9", "author": "Brown", "volume": "203", "first-page": "425", "year": "1988", "journal-title": "J Mol Biol", "DOI": "10.1016/0022-2836(88)90010-1", "doi-asserted-by": "crossref"}, {"key": "BIB10", "author": "Brown", "volume": "61", "first-page": "165", "year": "1997", "journal-title": "Mech Dev", "DOI": "10.1016/S0925-4773(96)00642-9", "doi-asserted-by": "crossref"}, {"key": "BIB11", "author": "Cai", "volume": "93", "first-page": "9309", "year": "1996", "journal-title": "Proc Natl Acad Sci U S A", "DOI": "10.1073/pnas.93.18.9309", "doi-asserted-by": "crossref"}, {"key": "BIB12", "author": "Campbell", "volume": "120", "first-page": "2957", "year": "1994", "journal-title": "Development"}, {"key": "BIB13", "author": "Campos", "volume": "28", "first-page": "313", "year": "1995", "journal-title": "J Neurobiol", "DOI": "10.1002/neu.480280305", "doi-asserted-by": "crossref"}, {"key": "BIB14", "author": "Casso", "volume": "88", "first-page": "229", "year": "1999", "journal-title": "Mech Dev", "DOI": "10.1016/S0925-4773(99)00174-4", "doi-asserted-by": "crossref"}, {"key": "BIB15", "author": "Casso", "volume": "91", "first-page": "451", "year": "2000", "journal-title": "Mech Dev", "DOI": "10.1016/S0925-4773(00)00248-3", "doi-asserted-by": "crossref"}, {"key": "BIB16", "author": "Chen", "volume": "249", "first-page": "1", "year": "2000", "journal-title": "Gene", "DOI": "10.1016/S0378-1119(00)00161-X", "doi-asserted-by": "crossref"}, {"key": "BIB17", "author": "Chen", "volume": "13", "first-page": "2218", "year": "1999", "journal-title": "Genes Dev", "DOI": "10.1101/gad.13.17.2218", "doi-asserted-by": "crossref"}, {"key": "BIB18", "author": "Cooper", "volume": "8", "first-page": "1400", "year": "1994", "journal-title": "Genes Dev", "DOI": "10.1101/gad.8.12.1400", "doi-asserted-by": "crossref"}, {"key": "BIB19", "author": "Courey", "volume": "15", "first-page": "2786", "year": "2001", "journal-title": "Genes Dev"}, {"key": "BIB20", "author": "Criqui-Filipe", "volume": "18", "first-page": "3392", "year": "1999", "journal-title": "EMBO J", "DOI": "10.1093/emboj/18.12.3392", "doi-asserted-by": "crossref"}, {"key": "BIB21", "author": "Cui", "volume": "116", "first-page": "943", "year": "1992", "journal-title": "Development"}, {"key": "BIB22", "author": "Doe", "volume": "333", "first-page": "376", "year": "1988", "journal-title": "Nature", "DOI": "10.1038/333376a0", "doi-asserted-by": "crossref"}, {"key": "BIB23", "author": "Duus", "volume": "151", "first-page": "34", "year": "1992", "journal-title": "Dev Biol", "DOI": "10.1016/0012-1606(92)90211-X", "doi-asserted-by": "crossref"}, {"key": "BIB24", "author": "Ellis", "volume": "119", "first-page": "855", "year": "1993", "journal-title": "Development"}, {"key": "BIB25", "author": "Fields", "volume": "5", "first-page": "116", "year": "1993", "journal-title": "Methods Enzymol", "DOI": "10.1006/meth.1993.1016", "doi-asserted-by": "crossref"}, {"key": "BIB26", "author": "Fields", "volume": "340", "first-page": "245", "year": "1989", "journal-title": "Nature", "DOI": "10.1038/340245a0", "doi-asserted-by": "crossref"}, {"key": "BIB27", "author": "Fields", "volume": "10", "first-page": "286", "year": "1994", "journal-title": "Trends Genet", "DOI": "10.1016/0168-9525(90)90012-U", "doi-asserted-by": "crossref"}, {"key": "BIB28", "author": "FlyBase", "volume": "27", "first-page": "85", "year": "1999", "journal-title": "Nucleic Acids Res", "DOI": "10.1093/nar/27.1.85", "doi-asserted-by": "crossref"}, {"key": "BIB29", "author": "Frommer", "volume": "15", "first-page": "1642", "year": "1996", "journal-title": "EMBO J"}, {"key": "BIB30", "author": "Guichet", "volume": "21", "first-page": "1661", "year": "2002", "journal-title": "EMBO J", "DOI": "10.1093/emboj/21.7.1661", "doi-asserted-by": "crossref"}, {"key": "BIB31", "author": "Halachmi", "volume": "67", "first-page": "275", "year": "1995", "journal-title": "Eur J Cell Biol"}, {"key": "BIB32", "author": "Halder", "volume": "267", "first-page": "1788", "year": "1995", "journal-title": "Science", "DOI": "10.1126/science.7892602", "doi-asserted-by": "crossref"}, {"key": "BIB33", "author": "Hanna-Rose", "volume": "12", "first-page": "229", "year": "1996", "journal-title": "Trends Genet", "DOI": "10.1016/0168-9525(96)10022-6", "doi-asserted-by": "crossref"}, {"key": "BIB34", "author": "Harrison", "volume": "139", "first-page": "1701", "year": "1995", "journal-title": "Genetics"}, {"key": "BIB35", "author": "Inostroza", "volume": "70", "first-page": "477", "year": "1992", "journal-title": "Cell", "DOI": "10.1016/0092-8674(92)90172-9", "doi-asserted-by": "crossref"}, {"key": "BIB36", "author": "Kambadur", "volume": "12", "first-page": "246", "year": "1998", "journal-title": "Genes Dev", "DOI": "10.1101/gad.12.2.246", "doi-asserted-by": "crossref"}, {"key": "BIB37", "author": "Keleher", "volume": "68", "first-page": "709", "year": "1992", "journal-title": "Cell", "DOI": "10.1016/0092-8674(92)90146-4", "doi-asserted-by": "crossref"}, {"key": "BIB38", "author": "Keller", "volume": "20", "first-page": "7247", "year": "2000", "journal-title": "Mol Cell Biol", "DOI": "10.1128/MCB.20.19.7247-7258.2000", "doi-asserted-by": "crossref"}, {"key": "BIB39", "author": "Klambt", "volume": "4", "first-page": "205", "year": "1991", "journal-title": "Glia", "DOI": "10.1002/glia.440040212", "doi-asserted-by": "crossref"}, {"key": "BIB40", "author": "Klein", "volume": "124", "first-page": "3123", "year": "1997", "journal-title": "Development"}, {"key": "BIB41", "author": "Kuchin", "volume": "92", "first-page": "4006", "year": "1995", "journal-title": "Proc Natl Acad Sci U S A", "DOI": "10.1073/pnas.92.9.4006", "doi-asserted-by": "crossref"}, {"key": "BIB42", "author": "Kunes", "volume": "13", "first-page": "752", "year": "1993", "journal-title": "J Neurosci."}, {"key": "BIB43", "author": "Landgraf", "volume": "22", "first-page": "43", "year": "1999", "journal-title": "Neuron", "DOI": "10.1016/S0896-6273(00)80677-7", "doi-asserted-by": "crossref"}, {"key": "BIB44", "author": "Loewen", "volume": "31", "first-page": "30", "year": "2001", "journal-title": "Genesis", "DOI": "10.1002/gene.10002", "doi-asserted-by": "crossref"}, {"key": "BIB45", "author": "Mellerick", "volume": "9", "first-page": "789", "year": "1992", "journal-title": "Neuron", "DOI": "10.1016/0896-6273(92)90234-5", "doi-asserted-by": "crossref"}, {"key": "BIB46", "author": "Murugasu-Oei", "volume": "57", "first-page": "91", "year": "1996", "journal-title": "Mech Dev", "DOI": "10.1016/0925-4773(96)00537-0", "doi-asserted-by": "crossref"}, {"key": "BIB47", "author": "Newsome", "volume": "127", "first-page": "851", "year": "2000", "journal-title": "Development"}, {"key": "BIB48", "author": "Nibu", "volume": "17", "first-page": "7009", "year": "1998a", "journal-title": "EMBO J", "DOI": "10.1093/emboj/17.23.7009", "doi-asserted-by": "crossref"}, {"key": "BIB49", "author": "Nibu", "volume": "280", "first-page": "101", "year": "1998b", "journal-title": "Science", "DOI": "10.1126/science.280.5360.101", "doi-asserted-by": "crossref"}, {"key": "BIB50", "author": "Patel", "volume": "3", "first-page": "890", "year": "1989", "journal-title": "Genes Dev", "DOI": "10.1101/gad.3.6.890", "doi-asserted-by": "crossref"}, {"key": "BIB51", "author": "Preston", "volume": "144", "first-page": "1611", "year": "1996", "journal-title": "Genetics"}, {"key": "BIB52", "author": "Preston", "volume": "144", "first-page": "1623", "year": "1996", "journal-title": "Genetics"}, {"key": "BIB53", "author": "Qu", "volume": "142", "first-page": "1075", "year": "1998", "journal-title": "J Cell Biol", "DOI": "10.1083/jcb.142.4.1075", "doi-asserted-by": "crossref"}, {"key": "BIB54", "author": "Rogers", "volume": "67", "first-page": "664", "year": "2000", "journal-title": "Am J Hum Genet", "DOI": "10.1086/303053", "doi-asserted-by": "crossref"}, {"key": "BIB55", "author": "Rushton", "volume": "121", "first-page": "1979", "year": "1995", "journal-title": "Development"}, {"key": "BIB56", "author": "Russo", "volume": "13", "first-page": "6858", "year": "1993", "journal-title": "Mol Cell Biol", "DOI": "10.1128/MCB.13.11.6858", "doi-asserted-by": "crossref"}, {"key": "BIB57", "author": "Russo", "volume": "92", "first-page": "6873", "year": "1995a", "journal-title": "Proc Natl Acad Sci U S A", "DOI": "10.1073/pnas.92.15.6873", "doi-asserted-by": "crossref"}, {"key": "BIB58", "author": "Russo", "volume": "92", "first-page": "6873", "year": "1995b", "journal-title": "Proc Natl Acad Sci U S A", "DOI": "10.1073/pnas.92.15.6873", "doi-asserted-by": "crossref"}, {"key": "BIB59", "author": "Salzberg", "volume": "147", "first-page": "1723", "year": "1997", "journal-title": "Genetics"}, {"key": "BIB60", "author": "Sambrook", "year": "1989", "unstructured": "1989. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press.", "volume-title": "Molecular cloning: a laboratory manual"}, {"key": "BIB61", "author": "Sanyal", "volume": "12", "first-page": "1363", "year": "2001", "journal-title": "Neuroreport", "DOI": "10.1097/00001756-200105250-00015", "doi-asserted-by": "crossref"}, {"key": "BIB62", "author": "Schmidt", "volume": "189", "first-page": "186", "year": "1997", "journal-title": "Dev Biol", "DOI": "10.1006/dbio.1997.8660", "doi-asserted-by": "crossref"}, {"key": "BIB63", "author": "Simpson", "volume": "58", "first-page": "237", "year": "1993", "journal-title": "Cold Spring Harb Symp Quant Biol", "DOI": "10.1101/SQB.1993.058.01.028", "doi-asserted-by": "crossref"}, {"key": "BIB64", "author": "Strunk", "volume": "239", "first-page": "229", "year": "2001", "journal-title": "Dev Biol", "DOI": "10.1006/dbio.2001.0454", "doi-asserted-by": "crossref"}, {"key": "BIB65", "author": "Sun", "volume": "124", "first-page": "3439", "year": "1997", "journal-title": "Development"}, {"key": "BIB66", "author": "Sundqvist", "volume": "429", "first-page": "183", "year": "1998", "journal-title": "FEBS Lett", "DOI": "10.1016/S0014-5793(98)00588-2", "doi-asserted-by": "crossref"}, {"key": "BIB67", "author": "Svaren", "volume": "16", "first-page": "3545", "year": "1996", "journal-title": "Mol Cell Biol", "DOI": "10.1128/MCB.16.7.3545", "doi-asserted-by": "crossref"}, {"key": "BIB68", "author": "Svaren", "volume": "17", "first-page": "6010", "year": "1998", "journal-title": "EMBO J", "DOI": "10.1093/emboj/17.20.6010", "doi-asserted-by": "crossref"}, {"key": "BIB69", "author": "Swirnoff", "volume": "18", "first-page": "512", "year": "1998", "journal-title": "Mol Cell Biol", "DOI": "10.1128/MCB.18.1.512", "doi-asserted-by": "crossref"}, {"key": "BIB70", "author": "Tautz", "volume": "98", "first-page": "81", "year": "1989", "journal-title": "Chromosoma", "DOI": "10.1007/BF00291041", "doi-asserted-by": "crossref"}, {"key": "BIB71", "author": "Timmerman", "volume": "52", "first-page": "1827", "year": "1999", "journal-title": "Neurology", "DOI": "10.1212/WNL.52.9.1827", "doi-asserted-by": "crossref"}, {"key": "BIB72", "author": "Vactor", "volume": "73", "first-page": "1137", "year": "1993", "journal-title": "Cell", "DOI": "10.1016/0092-8674(93)90643-5", "doi-asserted-by": "crossref"}, {"key": "BIB73", "author": "Wahi", "volume": "140", "first-page": "79", "year": "1995", "journal-title": "Genetics"}, {"key": "BIB74", "author": "Warner", "volume": "18", "first-page": "382", "year": "1998", "journal-title": "Nat Genet", "DOI": "10.1038/ng0498-382", "doi-asserted-by": "crossref"}, {"key": "BIB75", "author": "Wilson", "volume": "267", "first-page": "3718", "year": "1992", "journal-title": "J Biol Chem"}, {"key": "BIB76", "author": "Xu", "volume": "117", "first-page": "1223", "year": "1993", "journal-title": "Development"}, {"key": "BIB77", "author": "Yang", "volume": "11", "first-page": "1396", "year": "1997", "journal-title": "Genes Dev", "DOI": "10.1101/gad.11.11.1396", "doi-asserted-by": "crossref"}, {"key": "BIB78", "author": "Zhang", "volume": "96", "first-page": "535", "year": "1999", "journal-title": "Proc Natl Acad Sci U S A", "DOI": "10.1073/pnas.96.2.535", "doi-asserted-by": "crossref"}], "container-title": ["Developmental Dynamics"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fdvdy.10209", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/dvdy.10209", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 31]], "date-time": "2018-07-31T11:40:52Z", "timestamp": 1533037252000}, "score": 17.542576, "issued": {"date-parts": [[2002, 12, 30]]}, "references-count": 78, "journal-issue": {"published-print": {"date-parts": [[2003, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1002/dvdy.10209", "relation": {"cites": []}, "ISSN": ["1058-8388", "1097-0177"], "issn-type": [{"value": "1058-8388", "type": "print"}, {"value": "1097-0177", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T09:29:38Z", "timestamp": 1574760578698}, "reference-count": 0, "publisher": "CSIRO Publishing", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Aust. J. Chem."], "published-print": {"date-parts": [[1973]]}, "abstract": "<jats:p>3-O-Methylgalangin on\nreaction with prenyl bromide in the presence of methanolic methoxide gives\n6,8-di-C-prenyl and 6-C-prenyl derivatives in 17% and 10% yields respectively;\nwith 2-hydroxy-2-methylbut-3-ene it affords an 8-C-prenyl derivative besides\nthe above two compounds. The above di-C-prenyl derivative on oxidative\ncyclization with DDQ yields a mixture of a linear pyran (3-O-methylsericetin)\nand an angular pyran (3-O-methylisosericetin).\n\n\n\n\n\n</jats:p>", "DOI": "10.1071/ch9730641", "type": "journal-article", "created": {"date-parts": [[2017, 3, 20]], "date-time": "2017-03-20T03:23:40Z", "timestamp": 1489980220000}, "page": "641", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Synthesis of 3-O-methylsericetin and related compounds"], "prefix": "10.1071", "volume": "26", "author": [{"given": "AC", "family": "Jain", "sequence": "first", "affiliation": []}, {"given": "MK", "family": "Zutshi", "sequence": "additional", "affiliation": []}], "member": "67", "container-title": ["Australian Journal of Chemistry"], "language": "en", "link": [{"URL": "http://www.publish.csiro.au/CH/pdf/CH9730641", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 21]], "date-time": "2018-11-21T06:21:54Z", "timestamp": 1542781314000}, "score": 17.46318, "issued": {"date-parts": [[1973]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1973]]}, "issue": "3"}, "alternative-id": ["CH9730641"], "URL": "http://dx.doi.org/10.1071/ch9730641", "ISSN": ["0004-9425"], "issn-type": [{"value": "0004-9425", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T09:47:37Z", "timestamp": 1574329657442}, "publisher-location": "Amsterdam", "reference-count": 0, "publisher": "Science Wise Publishing", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2007]]}, "DOI": "10.3360/dis.2007.193", "type": "proceedings-article", "created": {"date-parts": [[2007, 11, 13]], "date-time": "2007-11-13T19:38:12Z", "timestamp": 1194982692000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Prospects for Inclusive Jet Cross-Section Measurement with Early Data at ATLAS"], "prefix": "10.5555", "author": [{"given": "Dan", "family": "Clements", "sequence": "first", "affiliation": []}], "member": "7822", "event": {"name": "15th International Workshop on Deep-Inelastic Scattering and Related Subjects", "theme": "Deep-Inelastic Scattering and Related Subjects", "location": "Munich, Germany", "acronym": "DIS 2007", "number": "15", "start": {"date-parts": [[2007, 4, 16]]}, "end": {"date-parts": [[2007, 4, 20]]}}, "container-title": ["15th International Workshop on Deep-Inelastic Scattering and Related Subjects DIS 2007"], "deposited": {"date-parts": [[2016, 3, 23]], "date-time": "2016-03-23T14:45:59Z", "timestamp": 1458744359000}, "score": 17.339417, "issued": {"date-parts": [[2007]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3360/dis.2007.193"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:28:20Z", "timestamp": 1574432900809}, "reference-count": 0, "publisher": "Bangladesh Journals Online (JOL)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cardiovasc. j."], "abstract": "<jats:p>DOI: http://dx.doi.org/10.3329/cardio.v3i2.9188Cardiovasc. J. 2011; 3(2): 178-186</jats:p>", "DOI": "10.3329/cardio.v3i2.9188", "type": "journal-article", "created": {"date-parts": [[2011, 12, 13]], "date-time": "2011-12-13T15:44:38Z", "timestamp": 1323791078000}, "page": "178-186", "source": "Crossref", "is-referenced-by-count": 0, "title": ["High-Sensitivity C-Reactive Protein and Cardiovascular Disease"], "prefix": "10.3329", "volume": "3", "author": [{"given": "MK", "family": "Mohsin", "sequence": "first", "affiliation": []}, {"given": "MU", "family": "Ahmed", "sequence": "first", "affiliation": []}], "member": "1861", "published-online": {"date-parts": [[1970, 1, 1]]}, "container-title": ["Cardiovascular Journal"], "link": [{"URL": "https://www.banglajol.info/index.php/CARDIO/article/download/9188/6758", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.banglajol.info/index.php/CARDIO/article/download/9188/6758", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 2]], "date-time": "2019-01-02T12:50:41Z", "timestamp": 1546433441000}, "score": 17.33569, "issued": {"date-parts": [[1970, 1, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2011, 12, 13]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.3329/cardio.v3i2.9188", "ISSN": ["2309-6357", "2071-0917"], "issn-type": [{"value": "2071-0917", "type": "print"}, {"value": "2309-6357", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:48:38Z", "timestamp": 1574153318250}, "reference-count": 0, "publisher": "Bioscientifica", "content-domain": {"domain": ["jme.bioscientifica.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2001, 2, 1]]}, "abstract": "<jats:p>ACTH-producing tumors of nonpituitary origin characteristically exhibit insensitivity to the negative feedback effects of glucocorticoids. In the DMS-79 cell line derived from an ACTH-producing small cell lung cancer we have previously identified an aberrantly spliced glucocorticoid receptor (GRDelta) that lacks a ligand-binding domain. We examined the interactions of this truncated form of GR with the proximal human proopiomelanocortin (POMC) promoter. In electrophoretic mobility shift assays GRDelta bound to the negative glucocorticoid response element (nGRE) at position -78 to -50 in the human POMC promoter. Nur77, an orphan nuclear receptor that exerts positive regulatory effects on the POMC gene is also known to bind to this DNA element. The functional properties of GR and GRDelta binding to this DNA element were examined in transient transfection experiments in murine AtT-20 corticotroph tumor cells. Reporter gene expression under the control of proximal POMC promoter elements was stimulated by addition of forskolin to the culture medium or by transfection with expression constructs for human Nak1, the human homologue of Nur77. Treatment of transfected cells with dexamethasone resulted in suppression of forskolin- or Nak1-stimulated POMC-reporter gene expression in the presence of co-transfected GR but not with GRDelta. The experiments indicate that in the human POMC promoter GRDelta is capable of binding to the nGRE but cannot effect trans-repression of POMC-reporter gene expression.</jats:p>", "DOI": "10.1677/jme.0.0260043", "type": "journal-article", "created": {"date-parts": [[2004, 12, 2]], "date-time": "2004-12-02T23:43:59Z", "timestamp": 1102031039000}, "page": "43-49", "update-policy": "http://dx.doi.org/10.1530/crossmarkpolicy-1", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Function of a truncated glucocorticoid receptor form at a negative glucocorticoid response element in the proopiomelanocortin gene"], "prefix": "10.1530", "author": [{"given": "MK", "family": "Turney", "sequence": "first", "affiliation": []}, {"given": "WJ", "family": "Kovacs", "sequence": "additional", "affiliation": []}], "member": "416", "container-title": ["Journal of Molecular Endocrinology"], "link": [{"URL": "https://jme.bioscientifica.com/view/journals/jme/26/1/43.xml", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 15]], "date-time": "2019-02-15T14:02:52Z", "timestamp": 1550239372000}, "score": 17.179014, "issued": {"date-parts": [[2001, 2, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1677/jme.0.0260043", "ISSN": ["0952-5041", "1479-6813"], "issn-type": [{"value": "0952-5041", "type": "print"}, {"value": "1479-6813", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:11:46Z", "timestamp": 1574799106982}, "reference-count": 0, "publisher": "Diva Enterprises Private Limited", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ind. Jour. of Path. and Onc."], "DOI": "10.5958/2394-6792.2016.00128.9", "type": "journal-article", "created": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T11:32:21Z", "timestamp": 1498217541000}, "page": "690", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Clinico-pathological study of breast carcinoma with correlation to hormone receptor status & HER2/neu"], "prefix": "10.5958", "volume": "3", "author": [{"given": "MK", "family": "Vedashree", "sequence": "first", "affiliation": []}, {"given": "V.", "family": "Rajalakshmi", "sequence": "additional", "affiliation": []}], "member": "4035", "published-online": {"date-parts": [[2016]]}, "container-title": ["Indian Journal of Pathology and Oncology"], "language": "en", "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T11:32:39Z", "timestamp": 1498217559000}, "score": 17.179014, "issued": {"date-parts": [[2016]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016]]}, "issue": "4"}, "alternative-id": ["S239467921706896X"], "URL": "http://dx.doi.org/10.5958/2394-6792.2016.00128.9", "ISSN": ["2394-6784", "2394-6792"], "issn-type": [{"value": "2394-6784", "type": "print"}, {"value": "2394-6792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T08:03:00Z", "timestamp": 1575273780796}, "reference-count": 0, "publisher": "Society for Neuroscience", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Neurosci."], "published-print": {"date-parts": [[1996, 4, 1]]}, "DOI": "10.1523/jneurosci.16-07-02172.1996", "type": "journal-article", "created": {"date-parts": [[2018, 4, 2]], "date-time": "2018-04-02T19:10:35Z", "timestamp": 1522696235000}, "page": "2172-2178", "source": "Crossref", "is-referenced-by-count": 44, "title": ["NMDA receptor upregulation: molecular studies in cultured mouse cortical neurons after chronic antagonist exposure"], "prefix": "10.1523", "volume": "16", "author": [{"given": "P", "family": "Follesa", "sequence": "first", "affiliation": []}, {"given": "MK", "family": "Ticku", "sequence": "additional", "affiliation": []}], "member": "393", "published-online": {"date-parts": [[1996, 4, 1]]}, "container-title": ["The Journal of Neuroscience"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1523/JNEUROSCI.16-07-02172.1996", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 4, 13]], "date-time": "2018-04-13T22:19:58Z", "timestamp": 1523657998000}, "score": 17.179014, "issued": {"date-parts": [[1996, 4, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[1996, 4, 1]]}, "published-print": {"date-parts": [[1996, 4, 1]]}, "issue": "7"}, "alternative-id": ["10.1523/JNEUROSCI.16-07-02172.1996"], "URL": "http://dx.doi.org/10.1523/jneurosci.16-07-02172.1996", "ISSN": ["0270-6474", "1529-2401"], "issn-type": [{"value": "0270-6474", "type": "print"}, {"value": "1529-2401", "type": "electronic"}], "subject": ["General Neuroscience"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T09:14:09Z", "timestamp": 1574414049568}, "reference-count": 0, "publisher": "Worldwide Protein Data Bank", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.2210/pdb3s8l/pdb", "type": "component", "created": {"date-parts": [[2011, 11, 1]], "date-time": "2011-11-01T19:00:39Z", "timestamp": 1320174039000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Protein-Ligand Interactions: Thermodynamic Effects Associated with Increasing Hydrophobic Surface Area"], "prefix": "10.2210", "author": [{"given": "J.H.", "family": "Clements", "sequence": "first", "affiliation": []}, {"given": "F.M.", "family": "Stephen", "sequence": "additional", "affiliation": []}], "member": "7763", "published-online": {"date-parts": [[2011, 11, 2]]}, "deposited": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T20:03:21Z", "timestamp": 1569873801000}, "score": 17.097723, "issued": {"date-parts": [[2011, 11, 2]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2210/pdb3s8l/pdb"}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T02:22:20Z", "timestamp": 1574216540354}, "reference-count": 79, "publisher": "Walter de Gruyter GmbH", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2006, 1, 1]]}, "DOI": "10.1515/bc.2006.088", "type": "journal-article", "created": {"date-parts": [[2006, 6, 26]], "date-time": "2006-06-26T14:42:27Z", "timestamp": 1151332947000}, "source": "Crossref", "is-referenced-by-count": 22, "title": ["Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?"], "prefix": "10.1515", "volume": "387", "author": [{"given": "Olivia L.", "family": "Tan", "sequence": "first", "affiliation": []}, {"given": "Astrid K.", "family": "Whitbread", "sequence": "additional", "affiliation": []}, {"given": "Judith A.", "family": "Clements", "sequence": "additional", "affiliation": []}, {"given": "Ying", "family": "Dong", "sequence": "additional", "affiliation": []}], "member": "374", "reference": [{"key": "ref1", "DOI": "10.1101/gr.10.7.1001", "doi-asserted-by": "publisher"}, {"key": "ref2", "DOI": "10.1002/pros.10076", "doi-asserted-by": "publisher"}, {"key": "ref3", "DOI": "10.1016/S0092-8674(00)00128-8", "doi-asserted-by": "publisher"}, {"key": "ref4", "author": "Black", "volume": "6", "first-page": "467", "year": "2000", "journal-title": "Clin. Cancer Res."}, {"key": "ref5", "DOI": "10.1038/nrc1474", "doi-asserted-by": "publisher"}, {"key": "ref6", "author": "Chang", "volume": "21", "first-page": "3147", "year": "2001", "journal-title": "Anticancer Res."}, {"key": "ref7", "author": "Chen", "volume": "27", "first-page": "1829", "year": "1994", "journal-title": "Braz. J. Med. Biol. Res."}, {"key": "ref8", "DOI": "10.1111/j.1471-4159.2004.02826.x", "doi-asserted-by": "publisher"}, {"key": "ref9", "DOI": "10.1080/10408360490471931", "doi-asserted-by": "publisher"}, {"key": "ref10", "DOI": "10.1074/jbc.M102285200", "doi-asserted-by": "publisher"}, {"key": "ref11", "DOI": "10.1053/gast.2002.31039", "doi-asserted-by": "publisher"}, {"key": "ref12", "author": "Dong", "volume": "7", "first-page": "2363", "year": "2001", "journal-title": "Clin. Cancer Res."}, {"key": "ref13", "author": "Dong", "volume": "9", "first-page": "1710", "year": "2003", "journal-title": "Clin. Cancer Res."}, {"key": "ref14", "DOI": "10.1677/erc.1.01062", "doi-asserted-by": "publisher"}, {"key": "ref15", "DOI": "10.1101/gad.1048803", "doi-asserted-by": "publisher"}, {"key": "ref16", "DOI": "10.1074/jbc.M107684200", "doi-asserted-by": "publisher"}, {"key": "ref17", "DOI": "10.1093/jnci/91.19.1635", "doi-asserted-by": "publisher"}, {"key": "ref18", "DOI": "10.1002/pros.10256", "doi-asserted-by": "publisher"}, {"key": "ref19", "DOI": "10.1016/S0168-9525(00)02176-4", "doi-asserted-by": "publisher"}, {"key": "ref20", "author": "Herrala", "volume": "43", "first-page": "279", "year": "1997", "journal-title": "Clin. Chem."}, {"key": "ref21", "author": "Heuze", "volume": "59", "first-page": "2820", "year": "1999", "journal-title": "Cancer Res."}, {"key": "ref22", "DOI": "10.1046/j.1432-1327.2001.02367.x", "doi-asserted-by": "publisher"}, {"key": "ref23", "DOI": "10.1046/j.1432-1033.2003.03425.x", "doi-asserted-by": "publisher"}, {"key": "ref24", "DOI": "10.1159/000020006", "doi-asserted-by": "publisher"}, {"key": "ref25", "DOI": "10.1006/geno.2000.6490", "doi-asserted-by": "publisher"}, {"key": "ref26", "DOI": "10.1126/science.1090100", "doi-asserted-by": "publisher"}, {"key": "ref27", "DOI": "10.1046/j.1523-1747.2003.12363.x", "doi-asserted-by": "publisher"}, {"key": "ref28", "DOI": "10.1089/104454901750361497", "doi-asserted-by": "publisher"}, {"key": "ref29", "DOI": "10.1261/rna.7100104", "doi-asserted-by": "publisher"}, {"key": "ref30", "DOI": "10.1016/S0378-1119(99)00210-3", "doi-asserted-by": "publisher"}, {"key": "ref31", "DOI": "10.1007/BF00210743", "doi-asserted-by": "publisher"}, {"key": "ref32", "DOI": "10.1002/1097-0045(20000801)44:3<248::AID-PROS10>3.0.CO;2-D", "doi-asserted-by": "publisher"}, {"key": "ref33", "DOI": "10.1038/nbt1195-1230", "doi-asserted-by": "publisher"}, {"key": "ref34", "DOI": "10.1159/000079147", "doi-asserted-by": "publisher"}, {"key": "ref35", "author": "Kurlender", "volume": "1755", "first-page": "1", "year": "2005", "journal-title": "Biochim. Biophys. Acta"}, {"key": "ref36", "DOI": "10.1038/35057062", "doi-asserted-by": "publisher"}, {"key": "ref37", "DOI": "10.1016/j.tig.2003.09.014", "doi-asserted-by": "publisher"}, {"key": "ref38", "DOI": "10.1006/bbrc.1999.1595", "doi-asserted-by": "publisher"}, {"key": "ref39", "author": "Magklara", "volume": "7", "first-page": "806", "year": "2001", "journal-title": "Clin. Cancer Res."}, {"key": "ref40", "DOI": "10.1074/jbc.M209807200", "doi-asserted-by": "publisher"}, {"key": "ref41", "author": "Meng", "volume": "11", "first-page": "305", "year": "2002", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "ref42", "DOI": "10.1016/S0163-7258(99)00067-4", "doi-asserted-by": "publisher"}, {"key": "ref43", "DOI": "10.1373/clinchem.2004.042341", "doi-asserted-by": "publisher"}, {"key": "ref44", "author": "Mignone", "volume": "3", "year": "2002", "journal-title": "Genome Biol.", "DOI": "10.1186/gb-2002-3-3-reviews0004", "doi-asserted-by": "crossref"}, {"key": "ref45", "DOI": "10.1002/1097-0045(20001101)45:3<271::AID-PROS11>3.0.CO;2-T", "doi-asserted-by": "publisher"}, {"key": "ref46", "DOI": "10.1046/j.1432-1327.1999.00213.x", "doi-asserted-by": "publisher"}, {"key": "ref47", "author": "Mitsui", "volume": "1494", "first-page": "206", "year": "2000", "journal-title": "Biochim. Biophys. Acta", "DOI": "10.1016/S0167-4781(00)00206-2", "doi-asserted-by": "crossref"}, {"key": "ref48", "DOI": "10.1006/bbrc.2000.2761", "doi-asserted-by": "publisher"}, {"key": "ref49", "DOI": "10.1038/ng0102-13", "doi-asserted-by": "publisher"}, {"key": "ref50", "DOI": "10.1002/pros.1119", "doi-asserted-by": "publisher"}, {"key": "ref51", "DOI": "10.1002/pros.10191", "doi-asserted-by": "publisher"}, {"key": "ref52", "DOI": "10.1016/S0090-4295(02)02443-3", "doi-asserted-by": "publisher"}, {"key": "ref53", "DOI": "10.1200/JCO.2003.11.007", "doi-asserted-by": "publisher"}, {"key": "ref54", "author": "Obiezu", "volume": "224", "first-page": "1", "year": "2005", "journal-title": "Cancer Lett.", "DOI": "10.1016/j.canlet.2004.09.024", "doi-asserted-by": "crossref"}, {"key": "ref55", "DOI": "10.1016/j.bbrc.2004.04.205", "doi-asserted-by": "publisher"}, {"key": "ref56", "DOI": "10.1016/S0378-1119(01)00674-6", "doi-asserted-by": "publisher"}, {"key": "ref57", "author": "Peter", "volume": "61", "first-page": "957", "year": "2001", "journal-title": "Cancer Res."}, {"key": "ref58", "DOI": "10.1126/science.289.5477.304", "doi-asserted-by": "publisher"}, {"key": "ref59", "DOI": "10.1016/S0162-3109(99)00059-4", "doi-asserted-by": "publisher"}, {"key": "ref60", "DOI": "10.1016/0006-291X(89)92409-1", "doi-asserted-by": "publisher"}, {"key": "ref61", "DOI": "10.1038/4328", "doi-asserted-by": "publisher"}, {"key": "ref62", "DOI": "10.1002/humu.9270", "doi-asserted-by": "publisher"}, {"key": "ref63", "author": "Slawin", "volume": "60", "first-page": "7142", "year": "2000", "journal-title": "Cancer Res."}, {"key": "ref64", "author": "Slim", "volume": "13", "first-page": "968", "year": "2002", "journal-title": "J. Am. Soc. Nephrol."}, {"key": "ref65", "DOI": "10.1016/S0959-437X(05)80059-0", "doi-asserted-by": "publisher"}, {"key": "ref66", "DOI": "10.1093/carcin/22.11.1775", "doi-asserted-by": "publisher"}, {"key": "ref67", "author": "Tanaka", "volume": "60", "first-page": "56", "year": "2000", "journal-title": "Cancer Res."}, {"key": "ref68", "author": "Underwood", "volume": "59", "first-page": "4435", "year": "1999", "journal-title": "Cancer Res."}, {"key": "ref69", "DOI": "10.1016/S1357-2725(98)00134-4", "doi-asserted-by": "publisher"}, {"key": "ref70", "DOI": "10.1126/science.1058040", "doi-asserted-by": "publisher"}, {"key": "ref71", "DOI": "10.1158/0008-5472.CAN-03-2025", "doi-asserted-by": "publisher"}, {"key": "ref72", "DOI": "10.1093/nar/gkg786", "doi-asserted-by": "publisher"}, {"key": "ref73", "DOI": "10.1093/nar/gkf492", "doi-asserted-by": "publisher"}, {"key": "ref74", "DOI": "10.1073/pnas.0409742102", "doi-asserted-by": "publisher"}, {"key": "ref75", "DOI": "10.1210/er.22.2.184", "doi-asserted-by": "publisher"}, {"key": "ref76", "DOI": "10.1159/000081384", "doi-asserted-by": "publisher"}, {"key": "ref77", "DOI": "10.1159/000087377", "doi-asserted-by": "publisher"}, {"key": "ref78", "DOI": "10.1084/jem.20020179", "doi-asserted-by": "publisher"}, {"key": "ref79", "author": "Zhao", "volume": "63", "first-page": "405", "year": "1999", "journal-title": "Microbiol. Mol. Biol. Rev."}], "container-title": ["Biological Chemistry"], "link": [{"URL": "https://www.degruyter.com/view/j/bchm.2006.387.issue-6/bc.2006.088/bc.2006.088.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T15:53:57Z", "timestamp": 1555689237000}, "score": 16.89215, "issued": {"date-parts": [[2006, 1, 1]]}, "references-count": 79, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.1515/bc.2006.088", "relation": {"cites": []}, "ISSN": ["1431-6730", "1437-4315"], "issn-type": [{"value": "1431-6730", "type": "print"}, {"value": "1437-4315", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T13:08:45Z", "timestamp": 1574514525554}, "reference-count": 19, "publisher": "Elsevier", "isbn-type": [{"value": "9780123822192", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013]]}, "DOI": "10.1016/b978-0-12-382219-2.00619-0", "type": "book-chapter", "created": {"date-parts": [[2012, 11, 10]], "date-time": "2012-11-10T20:43:25Z", "timestamp": 1352580205000}, "page": "2814-2817", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Kallikrein-related Peptidase 15 (Prostinogen)"], "prefix": "10.1016", "author": [{"given": "Jyotsna", "family": "Batra", "sequence": "first", "affiliation": []}, {"given": "Judith", "family": "Clements", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Handbook of Proteolytic Enzymes"], "deposited": {"date-parts": [[2019, 7, 5]], "date-time": "2019-07-05T13:32:32Z", "timestamp": 1562333552000}, "score": 16.793423, "issued": {"date-parts": [[2013]]}, "ISBN": ["9780123822192"], "references-count": 19, "URL": "http://dx.doi.org/10.1016/b978-0-12-382219-2.00619-0"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:54:11Z", "timestamp": 1574135651877}, "reference-count": 7, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4779, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002, 8]]}, "DOI": "10.1113/jphysiol.2002.025544", "type": "journal-article", "created": {"date-parts": [[2002, 10, 1]], "date-time": "2002-10-01T19:28:19Z", "timestamp": 1033500499000}, "page": "665-665", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Glycine receptor maturation: no experience required"], "prefix": "10.1113", "volume": "542", "author": [{"given": "J. D.", "family": "Clements", "sequence": "first", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2004, 7, 22]]}, "reference": [{"key": "10.1113/jphysiol.2002.025544-BIB1|cit1", "author": "Aamodt", "volume": "79", "first-page": "133", "year": "1999", "journal-title": "Advances in Neurology"}, {"key": "10.1113/jphysiol.2002.025544-BIB2|cit2", "author": "Ben-ari", "volume": "20", "first-page": "523", "year": "1997", "journal-title": "Trends in Neurosciences", "DOI": "10.1016/S0166-2236(97)01147-8", "doi-asserted-by": "crossref"}, {"key": "10.1113/jphysiol.2002.025544-BIB3|cit3", "author": "Betz", "volume": "868", "first-page": "667", "year": "1999", "journal-title": "Annals of the New York Academy of Sciences", "DOI": "10.1111/j.1749-6632.1999.tb11343.x", "doi-asserted-by": "crossref"}, {"key": "10.1113/jphysiol.2002.025544-BIB4|cit4", "author": "Lawrence", "volume": "20", "first-page": "4864", "year": "2000", "journal-title": "Journal of Neuroscience"}, {"key": "10.1113/jphysiol.2002.025544-BIB5|cit5", "author": "Legendre", "volume": "58", "first-page": "760", "year": "2001", "journal-title": "Cellular and Molecular Life Sciences", "DOI": "10.1007/PL00000899", "doi-asserted-by": "crossref"}, {"key": "10.1113/jphysiol.2002.025544-BIB6|cit6", "author": "Mangin", "volume": "542", "first-page": "685", "year": "2002", "journal-title": "Journal of Physiology", "DOI": "10.1113/jphysiol.2002.018978", "doi-asserted-by": "crossref"}, {"key": "10.1113/jphysiol.2002.025544-BIB7|cit7", "author": "Paysan", "volume": "5", "first-page": "179", "year": "1998", "journal-title": "Perspectives in Developmental Neurobiology"}], "container-title": ["The Journal of Physiology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1113%2Fjphysiol.2002.025544", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 15]], "date-time": "2017-06-15T12:02:30Z", "timestamp": 1497528150000}, "score": 16.749859, "issued": {"date-parts": [[2002, 8]]}, "references-count": 7, "journal-issue": {"published-print": {"date-parts": [[2002, 8]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1113/jphysiol.2002.025544", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0022-3751"], "issn-type": [{"value": "0022-3751", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:39:45Z", "timestamp": 1574246385987}, "reference-count": 44, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1991, 11, 1]], "date-time": "1991-11-01T00:00:00Z", "timestamp": 688953600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Behavioural Brain Research"], "published-print": {"date-parts": [[1991, 11]]}, "DOI": "10.1016/s0166-4328(05)80077-4", "type": "journal-article", "created": {"date-parts": [[2006, 11, 21]], "date-time": "2006-11-21T17:33:35Z", "timestamp": 1164130415000}, "page": "117-124", "source": "Crossref", "is-referenced-by-count": 38, "title": ["Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats"], "prefix": "10.1016", "volume": "45", "author": [{"given": "David", "family": "Eilam", "sequence": "first", "affiliation": []}, {"given": "Kathleen V.A.", "family": "Clements", "sequence": "additional", "affiliation": []}, {"given": "Henry", "family": "Szechtman", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Behavioural Brain Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0166432805800774?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0166432805800774?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 11]], "date-time": "2019-01-11T10:54:00Z", "timestamp": 1547204040000}, "score": 16.72334, "issued": {"date-parts": [[1991, 11]]}, "references-count": 44, "journal-issue": {"published-print": {"date-parts": [[1991, 11]]}, "issue": "2"}, "alternative-id": ["S0166432805800774"], "URL": "http://dx.doi.org/10.1016/s0166-4328(05)80077-4", "ISSN": ["0166-4328"], "issn-type": [{"value": "0166-4328", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T10:57:45Z", "timestamp": 1575197865246}, "reference-count": 0, "publisher": "BMJ", "issue": "Suppl 1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Eur J Hosp Pharm"], "published-print": {"date-parts": [[2013, 3]]}, "DOI": "10.1136/ejhpharm-2013-000276.499", "type": "journal-article", "created": {"date-parts": [[2013, 3, 12]], "date-time": "2013-03-12T11:55:35Z", "timestamp": 1363089335000}, "page": "A180.3-A180", "source": "Crossref", "is-referenced-by-count": 0, "title": ["CPC-042\u2005Drug-Related Problems in a Cardiology Department \u2013 Identifying Trends"], "prefix": "10.1136", "volume": "20", "author": [{"given": "T", "family": "Truelsh\u00f8j", "sequence": "first", "affiliation": []}, {"given": "MK", "family": "Hansen", "sequence": "additional", "affiliation": []}], "member": "239", "published-online": {"date-parts": [[2013, 3, 12]]}, "container-title": ["European Journal of Hospital Pharmacy"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/ejhpharm-2013-000276.499", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T19:58:27Z", "timestamp": 1482523107000}, "score": 16.713444, "issued": {"date-parts": [[2013, 3]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2013, 3, 12]]}, "published-print": {"date-parts": [[2013, 3]]}, "issue": "Suppl 1"}, "alternative-id": ["10.1136/ejhpharm-2013-000276.499"], "URL": "http://dx.doi.org/10.1136/ejhpharm-2013-000276.499", "ISSN": ["2047-9956", "2047-9964"], "issn-type": [{"value": "2047-9956", "type": "print"}, {"value": "2047-9964", "type": "electronic"}], "subject": ["General Pharmacology, Toxicology and Pharmaceutics"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:39:37Z", "timestamp": 1574113177267}, "reference-count": 33, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2000, 1, 1]], "date-time": "2000-01-01T00:00:00Z", "timestamp": 946684800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2000, 1]]}, "DOI": "10.1038/sj.leu.2401594", "type": "journal-article", "created": {"date-parts": [[2002, 9, 4]], "date-time": "2002-09-04T18:26:44Z", "timestamp": 1031164004000}, "page": "105-111", "source": "Crossref", "is-referenced-by-count": 50, "title": ["Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere"], "prefix": "10.1038", "volume": "14", "author": [{"given": "MK", "family": "Andersen", "sequence": "first", "affiliation": []}, {"given": "J", "family": "Pedersen-Bjergaard", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2000, 1, 6]]}, "reference": [{"key": "BF2401594_CR1", "first-page": "47", "volume": "19", "author": "EG Levine", "year": "1992", "unstructured": "Levine EG, Bloomfield CD . Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure Semin Oncol 1992 19: 47\u201384", "journal-title": "Semin Oncol"}, {"key": "BF2401594_CR2", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1016/S0889-8588(05)70340-3", "volume": "10", "author": "MJ Thirman", "year": "1996", "unstructured": "Thirman MJ, Larson RA . Therapy-related myeloid leukemia. Hematologic complications of cancer Hematol Oncol Clin North Am 1996 10: 293\u2013320", "journal-title": "Hematol Oncol Clin North Am"}, {"key": "BF2401594_CR3", "first-page": "256", "volume": "33", "author": "DJ Park", "year": "1996", "unstructured": "Park DJ, Koeffler HP . Therapy-related myelodysplastic syndromes Semin Hematol 1996 33: 256\u2013273", "journal-title": "Semin Hematol"}, {"key": "BF2401594_CR4", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1016/S0950-3536(96)80037-0", "volume": "9", "author": "FE Van Leeuwen", "year": "1996", "unstructured": "Van Leeuwen FE . Risk of acute myelogenous leukemia and myelodysplasia following cancer treatment Bailli\u00e8res Clin Haematol 1996 9: 57\u201385", "journal-title": "Bailli\u00e8res Clin Haematol"}, {"key": "BF2401594_CR5", "author": "CB Pratt", "first-page": "28", "year": "1991", "unstructured": "Pratt CB, Pui C-H . Second tumors after treatment with anticancer drugs. In: Powis G, Hacker MP (eds) The Toxicity of Anticancer Drugs Pergamon Press: New York 1991 28\u201343", "volume-title": "The Toxicity of Anticancer Drugs"}, {"key": "BF2401594_CR6", "doi-asserted-by": "publisher", "first-page": "207", "DOI": "10.1016/0165-4608(85)90085-8", "volume": "18", "author": "JMJC Scheres", "year": "1985", "unstructured": "Scheres JMJC, Hustinx TWJ, Geraedts JPM, Leeksma CHW, Meltzer PS . Translocation 1;7 in hematologic disorders: a brief review of 22 cases Cancer Genet Cytogenet 1985 18: 207\u2013213", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2401594_CR7", "doi-asserted-by": "publisher", "first-page": "128", "DOI": "10.1002/gcc.2870040205", "volume": "4", "author": "RE Kibbelaar", "year": "1992", "unstructured": "Kibbelaar RE, Mulder J-WR, van Kamp H, Dreef EJ, Wessels HW, Beverstock GC, Haak HL, Raap AK, Kluin PM . Nonradioactive in situ hybridisation of the translocation t(1;7) in myeloid malignancies Genes Chromos Cancer 1992 4: 128\u2013134", "journal-title": "Genes Chromos Cancer"}, {"key": "BF2401594_CR8", "doi-asserted-by": "publisher", "first-page": "282", "DOI": "10.1002/(SICI)1098-2264(199711)20:3<282::AID-GCC9>3.0.CO;2-Z", "volume": "20", "author": "P Wang", "year": "1997", "unstructured": "Wang P, Spielberger RT, Thangavelu M, Zhao N, Davis EM, Iannantuoni K, Larson RA, Le Beau MM . dic(5;17): a recurring abnormality in malignant disorders associated with mutations of TP53 Genes Chromos Cancer 1997 20: 282\u2013291", "journal-title": "Genes Chromos Cancer"}, {"key": "BF2401594_CR9", "doi-asserted-by": "publisher", "first-page": "56", "DOI": "10.1002/gcc.2870140110", "volume": "14", "author": "B Johansson", "year": "1995", "unstructured": "Johansson B, Arheden K, Hoglund M, Othz\u00e9n A, B\u00e9k\u00e1ssy AN, Turesson I, Heim S, Mitelman F . Fluorescence in situ hybridization analysis of whole-arm 7;12 translocations in hematologic malignancies Genes Chromos Cancer 1995 14: 56\u201362", "journal-title": "Genes Chromos Cancer"}, {"key": "BF2401594_CR10", "doi-asserted-by": "publisher", "first-page": "671", "DOI": "10.1038/sj.leu.2401365", "volume": "13", "author": "R Berger", "year": "1999", "unstructured": "Berger R, Coniat MBL . Centric and pericentric rearrangements in hematopoietic malignancies Leukemia 1999 13: 671\u2013678", "journal-title": "Leukemia"}, {"key": "BF2401594_CR11", "first-page": "712", "volume": "57", "author": "J Pedersen-Bjergaard", "year": "1981", "unstructured": "Pedersen-Bjergaard J, Philip P, Mortensen BT, Ersb\u00f8ll J, Jensen G, Panduro J, Thomsen M . Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typing Blood 1981 57: 712\u2013723", "journal-title": "Blood"}, {"key": "BF2401594_CR12", "doi-asserted-by": "publisher", "first-page": "452", "DOI": "10.1002/1097-0142(19840801)54:3<452::AID-CNCR2820540313>3.0.CO;2-9", "volume": "54", "author": "J Pedersen-Bjergaard", "year": "1984", "unstructured": "Pedersen-Bjergaard J, Philip P, Pedersen NT, Hou-Jensen K, Svejgaard A, Jensen G, Nissen N1 . Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients Cancer 1984 54: 452\u2013462", "journal-title": "Cancer"}, {"key": "BF2401594_CR13", "doi-asserted-by": "publisher", "first-page": "199", "DOI": "10.1111/j.1365-2141.1987.tb01299.x", "volume": "66", "author": "J Pedersen-Bjergaard", "year": "1987", "unstructured": "Pedersen-Bjergaard J, Philip P . Cytogenetic characteristics of therapy-related acute nonlymphocytic leukemia, preleukemia and acute myeloproliferative syndrome: correlation with clinical data for 61 consecutive cases Br J Haematol 1987 66: 199\u2013207", "journal-title": "Br J Haematol"}, {"key": "BF2401594_CR14", "first-page": "1083", "volume": "76", "author": "J Pedersen-Bjergaard", "year": "1990", "unstructured": "Pedersen-Bjergaard J, Philip P, Larsen SO, Jensen G, Byrsting K . Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia Blood 1990 76: 1083\u20131091", "journal-title": "Blood"}, {"key": "BF2401594_CR15", "first-page": "1975", "volume": "7", "author": "J Pedersen-Bjergaard", "year": "1993", "unstructured": "Pedersen-Bjergaard J, Philip P, Larsen SO, Andersson M, Daugaard G, Ersb\u00f8l J, Hansen SW, Hou-Jensen K, Nielsen D, Sigsgaard TC, Specht L, \u00d8sterlind K . Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series Leukemia 1993 7: 1975\u20131986", "journal-title": "Leukemia"}, {"key": "BF2401594_CR16", "first-page": "3542", "volume": "86", "author": "J Pedersen-Bjergaard", "year": "1995", "unstructured": "Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P . Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia Blood 1995 86: 3542\u20133552", "journal-title": "Blood"}, {"key": "BF2401594_CR17", "doi-asserted-by": "publisher", "first-page": "337", "DOI": "10.1002/(SICI)1098-2264(199812)23:4<337::AID-GCC9>3.0.CO;2-L", "volume": "23", "author": "J Pedersen-Bjergaard", "year": "1998", "unstructured": "Pedersen-Bjergaard J, Timshel S, Andersen MK, Andersen A-ST, Philip P . Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases Genes Chromos Cancer 1998 23: 337\u2013349", "journal-title": "Genes Chromos Cancer"}, {"key": "BF2401594_CR18", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1200/JCO.1986.4.3.325", "volume": "4", "author": "MM Le Beau", "year": "1986", "unstructured": "Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD . Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes Nos 5 and 7 J Clin Oncol 1986 4: 325\u2013345", "journal-title": "J Clin Oncol"}, {"key": "BF2401594_CR19", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1111/j.1600-0609.1991.tb00556.x", "volume": "47", "author": "B Johansson", "year": "1991", "unstructured": "Johansson B, Mertens F, Heim S, Kristofferson U, Mitelman F . Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL) Eur J Haematol 1991 47: 17\u201327", "journal-title": "Eur J Haematol"}, {"key": "BF2401594_CR20", "doi-asserted-by": "publisher", "first-page": "1748", "DOI": "10.1200/JCO.1986.4.12.1748", "volume": "4", "author": "HM Kantarjian", "year": "1986", "unstructured": "Kantarjian HM, Keating MJ, Walters RS, Smith TL, Cork A, McCredie KB, Freireich EJ . Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features J Clin Oncol 1986 4: 1748\u20131757", "journal-title": "J Clin Oncol"}, {"key": "BF2401594_CR21", "first-page": "759", "volume": "50", "author": "JD Rowley", "year": "1977", "unstructured": "Rowley JD, Golomb HM, Vardiman JW . Nonrandom chromosomal abnormalities in acute nonlymphocytic leukemia in patients treated for Hodgkin disease and non-Hodgkin lymphomas Blood 1977 50: 759\u2013770", "journal-title": "Blood"}, {"key": "BF2401594_CR22", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1016/0165-4608(89)90034-4", "volume": "43", "author": "A Iurlo", "year": "1989", "unstructured": "Iurlo A, Mecucci C, Orshoven AV, Michaux J-L, Boogaerts M, Noens L, Bosly A, Louwagie A, Van den Berghe H . Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome Cancer Genet Cytogenet 1989 43: 227\u2013241", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2401594_CR23", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1016/0165-4608(87)90134-8", "volume": "26", "author": "A Zaccaria", "year": "1987", "unstructured": "Zaccaria A, Alimena G, Baccarani M, Bilstrom R, Carbonell F, Castoldi GL, Fuscaldo K, Hecht F, Hossfeld DK, Mitelman F, Rosti G, Sandberg AA, Tassinari A, Testoni N, Tura S . Cytogenetic analysis in 89 patients with secondary hematologic disorders. Results of a cooperative study Cancer Genet Cytogenet 1987 26: 65\u201374", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2401594_CR24", "first-page": "403", "volume": "71", "author": "J Whang-Peng", "year": "1988", "unstructured": "Whang-Peng J, Young RC, Lee EC, Longo DL, Schechter GP, DeVita VT . Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities Blood 1988 71: 403\u2013414", "journal-title": "Blood"}, {"key": "BF2401594_CR25", "first-page": "1412", "volume": "70", "author": "MJ Ratain", "year": "1987", "unstructured": "Ratain MJ, Kaminer LS, Bitran JD, Larson RD, Le Beau MM, Skosey C, Purl S, Hoffman PC, Wade J, Vardiman JW, Daly K, Rowley JD, Golomb HM . Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung Blood 1987 70: 1412\u20131417", "journal-title": "Blood"}, {"key": "BF2401594_CR26", "doi-asserted-by": "publisher", "first-page": "136", "DOI": "10.1056/NEJM198907203210302", "volume": "321", "author": "C-H Pui", "year": "1989", "unstructured": "Pui C-H, Behm FG, Raimondi SC, Dodge RK, George SL, Rivera GK, Mirro J, Kalvinsky DK, Dahl GV, Murphy SB, Crist WM, Williams DL . Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia New Engl J Med 1989 321: 136\u2013142", "journal-title": "New Engl J Med"}, {"key": "BF2401594_CR27", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1016/0140-6736(91)90490-G", "volume": "338", "author": "J Pedersen-Bjergaard", "year": "1991", "unstructured": "Pedersen-Bjergaard J, Daugaard G, Hansen SW, Philip P, Larsen SO, R\u00f8rth M . Increased risk of myelodysplasia and leukemia after etoposide, cisplatin, and bleomycin for germ-cell tumours Lancet 1991 338: 359\u2013363", "journal-title": "Lancet"}, {"key": "BF2401594_CR28", "doi-asserted-by": "publisher", "first-page": "1444", "DOI": "10.1200/JCO.1992.10.9.1444", "volume": "10", "author": "J Pedersen-Bjergaard", "year": "1992", "unstructured": "Pedersen-Bjergaard J, Sigsgaard TC, Nielsen D, Gjedde SB, Philip P, Hansen M, Larsen SO, R\u00f8rth M, Mouridsen H, Dombernowsky P . Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer J Clin Oncol 1992 10: 1444\u20131451", "journal-title": "J Clin Oncol"}, {"key": "BF2401594_CR29", "first-page": "2780", "volume": "83", "author": "J Pedersen-Bjergaard", "year": "1994", "unstructured": "Pedersen-Bjergaard J, Rowley JD . The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation Blood 1994 83: 2780\u20132786", "journal-title": "Blood"}, {"key": "BF2401594_CR30", "doi-asserted-by": "publisher", "first-page": "1890", "DOI": "10.1200/JCO.1998.16.5.1890", "volume": "16", "author": "M Dissing", "year": "1998", "unstructured": "Dissing M, Le Beau MM, Pedersen-Bjergaard J . Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors? J Clin Oncol 1998 16: 1890\u20131896", "journal-title": "J Clin Oncol"}, {"key": "BF2401594_CR31", "first-page": "483", "volume": "83", "author": "MK Andersen", "year": "1998", "unstructured": "Andersen MK, Johansson B, Larsen SO, Pedersen-Bjergaard J . Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements Haematologica 1998 83: 483\u2013488", "journal-title": "Haematologica"}, {"key": "BF2401594_CR32", "doi-asserted-by": "publisher", "first-page": "729", "DOI": "10.1016/0092-8674(93)90493-A", "volume": "75", "author": "LL Sandell", "year": "1993", "unstructured": "Sandell LL, Zakian VA . Loss of a yeast telomere: arrest, recovery, and chromosome loss Cell 1993 75: 729\u2013739", "journal-title": "Cell"}, {"key": "BF2401594_CR33", "first-page": "1732", "volume": "91", "author": "JR Sawyer", "year": "1998", "unstructured": "Sawyer JR, Tricot G, Mattox S, Jagannath S, Barlogie B . Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin Blood 1998 91: 1732\u20131741", "journal-title": "Blood"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2401594.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2401594", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2401594.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T10:05:49Z", "timestamp": 1552730749000}, "score": 16.689, "issued": {"date-parts": [[2000, 1]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[2000, 1]]}, "issue": "1"}, "alternative-id": ["BF2401594"], "URL": "http://dx.doi.org/10.1038/sj.leu.2401594", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T23:05:10Z", "timestamp": 1575327910075}, "reference-count": 0, "publisher": "BMJ Publishing Group Ltd", "content-domain": {"domain": ["bmj.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2018, 6]]}, "DOI": "10.1136/esmoopen-2018-eacr25.191", "type": "proceedings-article", "created": {"date-parts": [[2018, 6, 30]], "date-time": "2018-06-30T06:04:24Z", "timestamp": 1530338664000}, "update-policy": "http://dx.doi.org/10.1136/crossmarkpolicy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["PO-147\u2005Pinostilbene hydrate suppresses human oral cancer cell metastasis via downregulation matrix metalloproteinase-2 through the mitogen-activated protein kinase signalling pathway"], "prefix": "10.1136", "author": [{"given": "CC", "family": "Lin", "sequence": "first", "affiliation": []}, {"given": "MK", "family": "Chen", "sequence": "additional", "affiliation": []}], "member": "239", "event": {"name": "Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June \u2013 3 July 2018"}, "container-title": ["Metastases and EMT"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/esmoopen-2018-EACR25.191", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 6, 30]], "date-time": "2018-06-30T06:10:01Z", "timestamp": 1530339001000}, "score": 16.604252, "issued": {"date-parts": [[2018, 6]]}, "references-count": 0, "alternative-id": ["10.1136/esmoopen-2018-EACR25.191"], "URL": "http://dx.doi.org/10.1136/esmoopen-2018-eacr25.191"}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}